This is a Validated Antibody Database (VAD) review about rat Parp1, based on 429 published articles (read how Labome selects the articles), using Parp1 antibody in all methods. It is aimed to help Labome visitors find the most suited Parp1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Parp1 synonym: ARTD1; Adprt; Parp-1

Knockout validation
Abcam
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:300; loading ...; fig 5s1g
Abcam Parp1 antibody (Abcam, ab227244) was used in immunohistochemistry knockout validation on mouse samples at 1:300 (fig 5s1g). elife (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (46D11)
  • immunocytochemistry knockout validation; human; 1:1000; loading ...; fig 2a
  • western blot knockout validation; human; 1:1000; loading ...; fig s3c
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Cell Signaling Technology Parp1 antibody (CST, 46D11) was used in immunocytochemistry knockout validation on human samples at 1:1000 (fig 2a), in western blot knockout validation on human samples at 1:1000 (fig s3c) and in immunohistochemistry - paraffin section on human samples (fig 4a). Molecules (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s2m
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot knockout validation on human samples (fig s2m). Mol Cell (2020) ncbi
Abcam
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 3c
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig s5b
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig s5b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; loading ...; fig 7f
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on human samples (fig 7f). Sci Adv (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; rat; loading ...; fig 1f
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on rat samples (fig 1f). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry - paraffin section; mouse; 4.8 ug/ml; loading ...; fig 4e
Abcam Parp1 antibody (Abcam, ab32064) was used in immunohistochemistry - paraffin section on mouse samples at 4.8 ug/ml (fig 4e). J Cell Commun Signal (2021) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; 1:700; loading ...; fig 2
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on human samples at 1:700 (fig 2). Int J Endocrinol (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:700; loading ...; fig 2
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:700 (fig 2). Int J Endocrinol (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; rat; 1:1000; loading ...; fig 2h
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on rat samples at 1:1000 (fig 2h). Front Cell Dev Biol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:300; loading ...; fig 5s1g
Abcam Parp1 antibody (Abcam, ab227244) was used in immunohistochemistry knockout validation on mouse samples at 1:300 (fig 5s1g). elife (2021) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; loading ...; fig 4a
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on human samples (fig 4a). Cells (2021) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; 1:1000; loading ...; fig 3c
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on human samples at 1:1000 (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:500; loading ...; fig 4i
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:500 (fig 4i). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (EPR18461)
  • western blot; human; 1:500; loading ...; fig 4i
Abcam Parp1 antibody (Abcam, ab191217) was used in western blot on human samples at 1:500 (fig 4i). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (EPR18461)
  • western blot; human; loading ...; fig 2c
Abcam Parp1 antibody (Abcam, ab191217) was used in western blot on human samples (fig 2c). Theranostics (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 2c
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples (fig 2c). Theranostics (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; rat; 1:1000; loading ...; fig 4a
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on rat samples at 1:1000 (fig 4a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; mouse; 1:1000; loading ...; fig 5g
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on mouse samples at 1:1000 (fig 5g). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (E102)
  • western blot; mouse; 1:1000; loading ...; fig 5g
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on mouse samples at 1:1000 (fig 5g). Cell Death Dis (2020) ncbi
domestic rabbit monoclonal (E51)
  • immunocytochemistry; human; loading ...; fig 1f
Abcam Parp1 antibody (Abcam, ab32064) was used in immunocytochemistry on human samples (fig 1f). Sci Rep (2020) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 4e
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples (fig 4e). Epigenetics (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 4h
Abcam Parp1 antibody (Abcam, Ab32064) was used in western blot on human samples at 1:1000 (fig 4h). Nat Commun (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 9c
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 9c). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:3000; loading ...; fig 3c
  • western blot; rat; fig 3c
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:3000 (fig 3c) and in western blot on rat samples (fig 3c). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 4c, 4f
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 4c, 4f). Science (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; loading ...; fig 5b
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples (fig 5b). Med Sci Monit (2019) ncbi
domestic rabbit monoclonal (EPR18461)
  • western blot; mouse; loading ...; fig s1a
Abcam Parp1 antibody (Abcam, ab191217) was used in western blot on mouse samples (fig s1a). Cell Res (2019) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4a, 4c, 4e
Abcam Parp1 antibody (Abcam, ab32138) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a, 4c, 4e). Hum Pathol (2019) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:20,000; loading ...; fig 3a
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:20,000 (fig 3a). EMBO Mol Med (2018) ncbi
domestic rabbit monoclonal (E51)
  • western blot; Spodoptera litura; fig 5j
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on Spodoptera litura samples (fig 5j). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; loading ...; fig 4a
Abcam Parp1 antibody (Abcam, E-102) was used in western blot on human samples (fig 4a). Oncogene (2017) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry; human; loading ...; fig 7d
  • western blot; human; loading ...; fig 5c
Abcam Parp1 antibody (Abcam, ab32064) was used in immunohistochemistry on human samples (fig 7d) and in western blot on human samples (fig 5c). Onco Targets Ther (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 9
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples (fig 9). Autophagy (2016) ncbi
domestic rabbit monoclonal (E102)
  • western blot; human; fig 9
Abcam Parp1 antibody (Abcam, ab32138) was used in western blot on human samples (fig 9). Autophagy (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 3b
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 3b). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 3
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples (fig 3). J Cancer (2016) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; fig 6i
Abcam Parp1 antibody (Abcam, ab 32064) was used in western blot on human samples (fig 6i). Sci Rep (2015) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - paraffin section; rat; 1:500; fig 6a
In order to examine the effects of hypothyroidism on late lactation, Abcam Parp1 antibody (Abcam, ab32138) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 6a). Mol Cell Endocrinol (2016) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry; mouse; 1:100; fig 5b
Abcam Parp1 antibody (Abcam, ab32064) was used in immunohistochemistry on mouse samples at 1:100 (fig 5b). Oncotarget (2015) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human; 1:1000; loading ...; fig 2a
Abcam Parp1 antibody (Abcam, ab32064) was used in western blot on human samples at 1:1000 (fig 2a). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (E51)
  • western blot; human
In order to evaluate the role of leptin/STAT3 and HER2 receptor in tamoxifen resistance, Abcam Parp1 antibody (Abcam, AB32064) was used in western blot on human samples . Cell Oncol (Dordr) (2015) ncbi
domestic rabbit monoclonal (E102)
  • immunohistochemistry - frozen section; rat; 1:50
Abcam Parp1 antibody (Abcam, Ab32138) was used in immunohistochemistry - frozen section on rat samples at 1:50. Mol Vis (2014) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry - frozen section; mouse; 2 ug/ml
In order to study mechanisms regulating SOCS expression during viral infection, Abcam Parp1 antibody (Abcam, ab32064) was used in immunohistochemistry - frozen section on mouse samples at 2 ug/ml. J Virol (2014) ncbi
domestic rabbit monoclonal (E51)
  • immunohistochemistry - paraffin section; fruit fly ; 1:1500
Abcam Parp1 antibody (Abcam, ab32064) was used in immunohistochemistry - paraffin section on fruit fly samples at 1:1500. Hum Mol Genet (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (10H)
  • western blot; mouse; loading ...
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-56198) was used in western blot on mouse samples . Int J Mol Sci (2021) ncbi
mouse monoclonal (B-10)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-74470) was used in western blot on human samples (fig 5a). Sci Rep (2021) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:2500; loading ...; fig s5b
Santa Cruz Biotechnology Parp1 antibody (Santa, sc-8007) was used in western blot on human samples at 1:2500 (fig s5b). NPJ Precis Oncol (2021) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 2e). Mol Cancer (2020) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 3c
Santa Cruz Biotechnology Parp1 antibody (Santa cruz, F2) was used in western blot on human samples (fig 3c). PLoS Pathog (2019) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig s13h
Santa Cruz Biotechnology Parp1 antibody (SCBT, 8007) was used in western blot on mouse samples (fig s13h). Science (2019) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, F-2) was used in western blot on human samples (fig 3a). PLoS ONE (2019) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology Parp1 antibody (Santa, E-8) was used in western blot on mouse samples (fig 1b). Cell Death Dis (2019) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 2a
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (D-1)
  • chromatin immunoprecipitation; human; loading ...; fig s4b
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-365315) was used in chromatin immunoprecipitation on human samples (fig s4b). Nat Commun (2018) ncbi
mouse monoclonal (F-2)
  • immunoprecipitation; mouse; 1:1000; loading ...; fig 1b
  • western blot; mouse; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in immunoprecipitation on mouse samples at 1:1000 (fig 1b) and in western blot on mouse samples at 1:1000 (fig 1b). Cell Death Differ (2018) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 7d
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc-53643) was used in western blot on human samples (fig 7d). Cell (2018) ncbi
mouse monoclonal (C2-10)
  • western blot; mouse; fig s5e
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc-53643) was used in western blot on mouse samples (fig s5e). Cell (2018) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 3f
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, SC-8007) was used in western blot on human samples (fig 3f). Oncotarget (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 5n
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 5n). Gut (2018) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, SC-8007) was used in western blot on human samples (fig 2e). Mol Cell Biol (2017) ncbi
mouse monoclonal (42)
  • western blot; human; 1:2500; loading ...; fig 4C
Santa Cruz Biotechnology Parp1 antibody (Santa cruz, sc-136208) was used in western blot on human samples at 1:2500 (fig 4C). Mol Med Rep (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 1d
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 2c
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, 8007) was used in western blot on human samples (fig 2c). Nucleic Acids Res (2017) ncbi
mouse monoclonal (C2-10)
  • western blot; human; loading ...; fig 4c
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-53643) was used in western blot on human samples (fig 4c). Cell Death Dis (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig s4a
In order to analyze the effect of CX-5461 as a G-quadruplex DNA stabilizer, Santa Cruz Biotechnology Parp1 antibody (Santa CruZ, SC-8007) was used in western blot on human samples at 1:1000 (fig s4a). Nat Commun (2017) ncbi
mouse monoclonal (5A5)
  • western blot; human; loading ...; fig 5f
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 5f). PLoS Pathog (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; loading ...; fig 6d
In order to examine if SMSr-SAM is structurally and functionally related to the SAM domain of diacylglycerol kinase DGKd, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc8007) was used in western blot on human samples at 1:1000 (fig 6d). Sci Rep (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4c
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc8007) was used in western blot on human samples (fig 4c). Expert Opin Ther Targets (2017) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 6e
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 6e). Oncotarget (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4h
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc-8007) was used in western blot on human samples (fig 4h). PLoS ONE (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, SC-8007) was used in western blot on human samples (fig 5b). Oncotarget (2016) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; loading ...; fig 5
In order to discuss targeting mTOR-signaling and lactate dehydrogenase A as a strategy to treat colorectal cancer, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on mouse samples (fig 5). J Cancer (2016) ncbi
mouse monoclonal (E-8)
  • immunocytochemistry; human; fig 1
In order to assess the effects of combining PARP-1 inhibition with carbon ion exposure to control metastatic cells, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-74469) was used in immunocytochemistry on human samples (fig 1). Radiat Oncol (2016) ncbi
mouse monoclonal (F-2)
  • western blot; mouse; 1:500; loading ...; fig 4c
In order to test if alpha7nAChR in adipocytes may inhibit acylation stimulating protein-induced inflammation, Santa Cruz Biotechnology Parp1 antibody (Santa cruz, sc-8007) was used in western blot on mouse samples at 1:500 (fig 4c). Mol Med Rep (2016) ncbi
mouse monoclonal (E-8)
  • western blot; human; fig 2
Santa Cruz Biotechnology Parp1 antibody (santa Cruz, sc-74469) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:500; fig 4
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, Sc-8007) was used in western blot on human samples at 1:500 (fig 4). Future Oncol (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; fig 3
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (10H)
  • immunoprecipitation; fruit fly ; fig 4
Santa Cruz Biotechnology Parp1 antibody (santa Cruz, sc-56198) was used in immunoprecipitation on fruit fly samples (fig 4). PLoS Genet (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 2c
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples (fig 2c). PLoS ONE (2016) ncbi
mouse monoclonal (C2-10)
  • immunocytochemistry; mouse; fig 4
  • western blot; mouse; 1:1000; fig s4
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-53643) was used in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples at 1:1000 (fig s4). Nat Commun (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 4
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc8007) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000; fig s1
In order to assess the interference of HCV replication through the autolysosomal degradation of NS5A by the interferon-inducible protein SCOTIN, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1c
Santa Cruz Biotechnology Parp1 antibody (SantaCruz, sc-8007) was used in western blot on human samples (fig 1c). Mol Cell Biol (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig 1). Oxid Med Cell Longev (2016) ncbi
mouse monoclonal (F-2)
  • immunohistochemistry - paraffin section; human; fig st1
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in immunohistochemistry - paraffin section on human samples (fig st1). PLoS ONE (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 1c
In order to investigate the role of mitochondrial ATR during the response to UV damage, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples (fig 1c). Mol Cell (2015) ncbi
mouse monoclonal (5A5)
  • western blot; human; fig 4
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (10H)
  • western blot; human; loading ...; fig 4
Santa Cruz Biotechnology Parp1 antibody (Santa, sc-56198) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig 4
Santa Cruz Biotechnology Parp1 antibody (Santa, sc-8007) was used in western blot on human samples (fig 4). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; loading ...; fig st2
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples (fig st2). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 6
In order to study the role of transmembrane protein 33 in the unfolded protein response, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, F-2) was used in western blot on human samples (fig 6). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal (5A5)
  • western blot; human; fig 2
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-56197) was used in western blot on human samples (fig 2). Acta Pharmacol Sin (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:2000; fig 6
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, SC- 8007) was used in western blot on human samples at 1:2000 (fig 6). Melanoma Res (2015) ncbi
mouse monoclonal (D-1)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-365315) was used in western blot on human samples (fig 4a). Sci Rep (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology Parp1 antibody (santa Cruz, sc-8007) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (C2-10)
  • western blot; human; fig 5C
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-53643) was used in western blot on human samples (fig 5C). Oncotarget (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
In order to study myocardial infarction-induced cardiomyocyte apoptosis in the context of sialylation of heart, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, SC-8007) was used in western blot on human samples . Basic Res Cardiol (2015) ncbi
mouse monoclonal (3H2844)
  • western blot; rat; fig 1
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-71848) was used in western blot on rat samples (fig 1). Neurotox Res (2015) ncbi
mouse monoclonal (B-10)
  • western blot; human
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-74470) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (B-10)
  • western blot; human; fig 3a
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-74470) was used in western blot on human samples (fig 3a). Nucleic Acids Res (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples . Mol Cancer Res (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; fig s3
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnologies, sc8007) was used in western blot on human samples (fig s3). Oncogene (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:500
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:500. Cancer Cell (2014) ncbi
mouse monoclonal (F-2)
  • western blot; human
In order to determine if inhibition of AKT signaling augments erlotinib activity and abrogates HGF-mediated resistance, Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-8007) was used in western blot on human samples . J Cancer Res Clin Oncol (2015) ncbi
mouse monoclonal (F-2)
  • western blot; human
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (E-8)
  • chromatin immunoprecipitation; mouse; loading ...; fig s6a
  • immunocytochemistry; mouse; loading ...; fig 1e
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, sc-74469x) was used in chromatin immunoprecipitation on mouse samples (fig s6a) and in immunocytochemistry on mouse samples (fig 1e). Nucleic Acids Res (2014) ncbi
mouse monoclonal (D-1)
  • western blot; human; fig 7
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz Biotechnology, SC-365315) was used in western blot on human samples (fig 7). Br J Nutr (2014) ncbi
mouse monoclonal (F-2)
  • western blot; human; 1:1000
Santa Cruz Biotechnology Parp1 antibody (Santa Cruz, sc-8007) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2011) ncbi
Enzo Life Sciences
mouse monoclonal (C-2-10)
  • western blot; mouse; fig 2
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA249) was used in western blot on mouse samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3b
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA253) was used in western blot on human samples at 1:2000 (fig 3b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig 3b
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA253) was used in western blot on human samples at 1:2000 (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:1000; fig 6
Enzo Life Sciences Parp1 antibody (Biomol, SA250) was used in western blot on human samples at 1:1000 (fig 6). Biochem Pharmacol (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:3000; fig 1a
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA250) was used in western blot on human samples at 1:3000 (fig 1a). Mol Oncol (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 3
Enzo Life Sciences Parp1 antibody (Enzo Life Sciences, C-2-10) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; loading ...; fig 5b
Enzo Life Sciences Parp1 antibody (Enzo, C-2-10) was used in western blot on human samples (fig 5b). Cell Death Differ (2016) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to determine the action of PARP inhibition in different glioblastoma multiforme cell lines, Enzo Life Sciences Parp1 antibody (ALEXIS, C2-10) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 3
In order to analyze ABT737 resistance in squamous cell carcinoma of the skin determined by the ratio of Mcl-1 and Noxa, Enzo Life Sciences Parp1 antibody (Biomol, C-2-10) was used in western blot on human samples (fig 3). Cell Death Dis (2014) ncbi
mouse monoclonal (C-2-10)
  • western blot; mouse
  • western blot; human; fig 3
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA250) was used in western blot on mouse samples and in western blot on human samples (fig 3). J Biol Chem (2014) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:1000
Enzo Life Sciences Parp1 antibody (Enzo, BML-SA250) was used in western blot on human samples at 1:1000. PLoS Pathog (2013) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to study the mechanism for enterovirulence of Escherichia coli strain C1845, Enzo Life Sciences Parp1 antibody (Enzo Life Sciences, C2-10) was used in western blot on human samples . Infect Immun (2010) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
Enzo Life Sciences Parp1 antibody (Biomol, C-2-10) was used in western blot on human samples . J Neurooncol (2010) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
Enzo Life Sciences Parp1 antibody (Alexis Biochemicals, C2-10) was used in western blot on human samples . J Biol Chem (2009) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to examine the hepatotoxicity of TRAIL/bortezomib cotreatment, Enzo Life Sciences Parp1 antibody (Biomol, C-2-10) was used in western blot on human samples . Hepatology (2007) ncbi
mouse monoclonal (C-2-10)
  • western blot; rhesus macaque
In order to study the activation of Bax during rotavirus-induced apoptosis, Enzo Life Sciences Parp1 antibody (Biomol, C-2-10) was used in western blot on rhesus macaque samples . J Virol (2007) ncbi
Invitrogen
domestic rabbit monoclonal (C.384.8)
  • western blot; human; loading ...; fig 4c
Invitrogen Parp1 antibody (pierce, MA5-15031) was used in western blot on human samples (fig 4c). Front Genet (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5c
In order to explore the use of bacterial carriers in a rat model of glioblastoma, Invitrogen Parp1 antibody (Thermo Fisher, 44-698G) was used in immunohistochemistry - paraffin section on rat samples (fig 5c). Mol Ther Oncolytics (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 6
In order to study the generation of homogenous three-dimensional pancreatic cancer cell spheroids and their improved hanging drop technique, Invitrogen Parp1 antibody (Thermo Fisher, PA5-16452) was used in immunohistochemistry - paraffin section on human samples (fig 6). Tissue Eng Part C Methods (2016) ncbi
mouse monoclonal (123)
  • western blot; human; fig 3
In order to report that USP17 interacts with HDAC2, Invitrogen Parp1 antibody (Invitrogen, 436400) was used in western blot on human samples (fig 3). Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (123)
  • western blot; human; fig 3
In order to investigate how IL-33 regulates IL-13 gene expression, Invitrogen Parp1 antibody (Invitrogen, 436400) was used in western blot on human samples (fig 3). Int J Mol Sci (2015) ncbi
mouse monoclonal (123)
  • western blot; human; fig 1
In order to study the involvement of TIMELESS in the PARP1-mediated DNA damage response, Invitrogen Parp1 antibody (Invitrogen, 436400) was used in western blot on human samples (fig 1). Cell Rep (2015) ncbi
mouse monoclonal (123)
  • immunoprecipitation; human; fig 1
In order to study the effect of ubiquitination modification in regulating the protein stability and the nuclear function of IL-33, Invitrogen Parp1 antibody (Invitrogen, 436400) was used in immunoprecipitation on human samples (fig 1). Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (C-2-10)
  • immunohistochemistry - paraffin section; human; 1:1500
  • western blot; human; 1:1500
In order to study the involvement of decreased parkin solubility and reduced nigrostriatum autophagy in sporadic Parkinson's disease, Invitrogen Parp1 antibody (Pierce, MA3-950) was used in immunohistochemistry - paraffin section on human samples at 1:1500 and in western blot on human samples at 1:1500. Neuroscience (2013) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to investigate the interaction between HOXB7 and poly (ADP-ribose) polymerase-1, Invitrogen Parp1 antibody (Invitrogen, C-2-10) was used in western blot on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (C-2-10)
  • western blot; human
In order to investigate the cellular localization and function of negative transcription elongation factor , Invitrogen Parp1 antibody (Affinity Bioreagents, MA3-950) was used in western blot on human samples . Exp Cell Res (2009) ncbi
mouse monoclonal (C-2-10)
  • western blot; mouse; 1:1000; fig 1A
In order to characterize defects in harlequin mutant mice, Invitrogen Parp1 antibody (Zymed, C-2-10) was used in western blot on mouse samples at 1:1000 (fig 1A). Cell Death Differ (2007) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; fig 2
In order to identify pathways that are constitutively activated in a KIT-dependent manner in gastrointestinal stromal tumors, Invitrogen Parp1 antibody (Zymed, C-2-10) was used in western blot on human samples (fig 2). Oncogene (2004) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; fig 6c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542T) was used in western blot on mouse samples (fig 6c). PLoS Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 1b
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on rat samples at 1:1000 (fig 1b). J Neuroinflammation (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:1000 (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig s2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on rat samples (fig s2). Gut Microbes (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples at 1:1000 (fig 3e). Neurooncol Adv (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology Parp1 antibody (Cell signaling technology, 9542) was used in western blot on human samples . Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7e
Cell Signaling Technology Parp1 antibody (Cell signaling technology, 9545) was used in western blot on human samples (fig 7e). Nat Commun (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples (fig 2a). Cell Death Discov (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 2f
Cell Signaling Technology Parp1 antibody (CST, 9545) was used in western blot on rat samples (fig 2f). Cell Rep (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1c). BMC Cancer (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 3d). J Biomed Sci (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s1c
Cell Signaling Technology Parp1 antibody (Cell Signalling Technology, 9542) was used in western blot on human samples at 1:1000 (fig s1c). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 5d). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3g, s4d
Cell Signaling Technology Parp1 antibody (CST, 9542S) was used in western blot on human samples (fig 3g, s4d). Neoplasia (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3f, 4e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3f, 4e). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 3e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 3e). Oncogene (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 5e). Theranostics (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:5000; fig 1c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:5000 (fig 1c). Neuro Oncol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1i
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples at 1:1000 (fig 1i). Nat Commun (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4c, 4e
Cell Signaling Technology Parp1 antibody (Cell signaling technology, 9532) was used in western blot on human samples (fig 4c, 4e). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2f
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples (fig 2f). Nat Cell Biol (2021) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532S) was used in western blot on human samples (fig 4a). Sci Rep (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 2a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (46D11)
  • immunocytochemistry knockout validation; human; 1:1000; loading ...; fig 2a
  • western blot knockout validation; human; 1:1000; loading ...; fig s3c
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Cell Signaling Technology Parp1 antibody (CST, 46D11) was used in immunocytochemistry knockout validation on human samples at 1:1000 (fig 2a), in western blot knockout validation on human samples at 1:1000 (fig s3c) and in immunohistochemistry - paraffin section on human samples (fig 4a). Molecules (2020) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s2m
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot knockout validation on human samples (fig s2m). Mol Cell (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:400; loading ...; fig 5d
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542S) was used in western blot on mouse samples at 1:400 (fig 5d). Nat Commun (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 6b). Antioxidants (Basel) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 7a). Asian Pac J Cancer Prev (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2b). Cell Commun Signal (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 6f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6f). Cells (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 6c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 6c). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6e
  • western blot; mouse; loading ...; fig 3b
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples (fig 6e) and in western blot on mouse samples (fig 3b). Sci Rep (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 5c). Oncol Rep (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 6a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples (fig 6a). Autophagy (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 6b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2e
Cell Signaling Technology Parp1 antibody (Cell Signalling Technology, 9542) was used in western blot on human samples at 1:1000 (fig 2e). elife (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 2a). BMC Complement Med Ther (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532S) was used in western blot on human samples (fig 5b). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 7a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 7a). elife (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532S) was used in western blot on human samples (fig 1c). Cancer Res (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3e, 4e, 5e
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, Inc., #9542) was used in western blot on human samples at 1:1000 (fig 3e, 4e, 5e). Chem Biol Drug Des (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2500; fig 1a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:2500 (fig 1a). Oncogene (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 3d
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, #9532) was used in western blot on mouse samples at 1:1000 (fig 3d). EBioMedicine (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 5c). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples (fig 4b). FASEB Bioadv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology Parp1 antibody (Cell signaling Technology, 9542) was used in western blot on human samples (fig 4i). Mol Cancer (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 1b). Oncogenesis (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3c). Cancer Cell Int (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3d). J Cancer (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Parp1 antibody (CST, 46D11) was used in western blot on human samples (fig 4g). EBioMedicine (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 6e
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples at 1:1000 (fig 6e). Genes Cancer (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 5d). Oncogene (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s5a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s5a). J Exp Med (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; loading ...; fig s3f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:2000 (fig s3f). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 2g
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 2g). Nat Commun (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542S) was used in western blot on human samples (fig 5c). Mod Pathol (2020) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 7b). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7f). Cancer Cell (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4a). EMBO Mol Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6b). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig s2a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s2a). Cell (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6a). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology Parp1 antibody (Cell Signalling Technology, 9542) was used in western blot on human samples (fig 4d). J Cell Mol Med (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology Parp1 antibody (Cell Signalling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 4d). EMBO Mol Med (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig s2d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s2d). Science (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3b). Int J Oncol (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 4c). J Biol Chem (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2e). Cancer Cell Int (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples (fig 1c). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig e8d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig e8d). Nature (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6f
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 6f). Front Mol Neurosci (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s1a). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 7a). Exp Cell Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1b). Nature (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples (fig 5a). Toxicology (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1d). Genes Dev (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 7d). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 5f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 5f). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s1a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig s1a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1s1b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1s1b). elife (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s1
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig s1). Methods (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s4g
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:1000 (fig s4g). Nat Cell Biol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8g
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542L) was used in western blot on human samples at 1:1000 (fig 8g). EMBO J (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s15a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532S) was used in western blot on human samples (fig s15a). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s4). Oncogene (2019) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 4e
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples (fig 4e). Cell Death Dis (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 2c). Nat Med (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 1j
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1j). Nat Cell Biol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig s3a). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2c). Front Immunol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 2a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 2a). Life Sci (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3d
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3d). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on mouse samples (fig 1d). Cell Mol Immunol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3g
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3g). Nat Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 5a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 9b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 9b). Int J Biochem Cell Biol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2e). Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1i
  • western blot; human; loading ...; fig 1i
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on mouse samples (fig 1i) and in western blot on human samples (fig 1i). J Clin Invest (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 4c). Neoplasia (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig s4f). Oncotarget (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology Parp1 antibody (Cell Signalling, 9532) was used in western blot on mouse samples (fig 3a). J Mol Biol (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2b). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2b). Tumour Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:500; loading ...; fig 4c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:500 (fig 4c). Cell Death Dis (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3a). Clin Cancer Res (2018) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 1h
In order to study induction of cell death by low frequency magnetic fields, Cell Signaling Technology Parp1 antibody (Cell Signalling, 9532) was used in western blot on mouse samples at 1:1000 (fig 1h). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1b). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; fig 1a
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples at 1:1000 (fig 1a). Nat Cell Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig s9b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s9b). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 1d). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1d
Cell Signaling Technology Parp1 antibody (Cell signal, 9542s) was used in western blot on human samples (fig s1d). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s5f). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s1d
Cell Signaling Technology Parp1 antibody (Cell signal, 9542s) was used in western blot on human samples (fig s1d). Nature (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5d
In order to understand the role of nicotinamide metabolism in the maintenance of glioblastoma stem cells, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 5d). JCI Insight (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s5b
In order to study the effect of GNAQ mutations and GNA11/MAPK pathway activation in uveal melanoma, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig s5b). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5e
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5e). Biochem Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 11c
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 11c). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3a
In order to show that PHB1 is highly expressed in non-small cell lung cancers patients and correlates with poor survival, Cell Signaling Technology Parp1 antibody (Cell Signalling, 9542) was used in western blot on human samples (fig s3a). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2
Cell Signaling Technology Parp1 antibody (cell signalling, 9542) was used in western blot on human samples (fig 2). Neoplasia (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 7a
In order to study the synergistic antitumor effect of simultaneously targeting CD47 and autophagy in non-small cell lung cancer, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 7a). Cancer Immunol Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1c). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 2g
In order to analyze the contributions of developmental Hedgehog signaling effectors HDAC1 and HDAC2 in SHH Medulloblastoma, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542 S) was used in western blot on mouse samples at 1:1000 (fig 2g). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3k, 5i, 6f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 3k, 5i, 6f). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples . Mol Ther (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology Parp1 antibody (Cell Signalling, 9542) was used in western blot on human samples (fig 4d). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:1000 (fig 1a). Mol Cell Biol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:1000 (fig 1b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 2a, 2b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 2a, 2b). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 2a
In order to determine that Krupple-like factor 10 silencing correlates with enhanced pancreatic cancer clonogenic survival and murine tumor growth after radiation, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 2a). Radiother Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:1000 (fig 8b). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 8c
In order to show that quercetin inhibits the PI3K/AKT/mTOR and STAT3 pathways in primary effusion lymphoma, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 8c). J Nutr Biochem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6a
In order to quantify changes in cytoplasmic and mitochondrial interactomes in response to apoptosis initiation as a function of caspase activity, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6a). Mol Syst Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2a
In order to propose a new role for PACS1 as a regulator of the intrinsic pathway of apoptosis and mitochondrial outer membrane permeabilization, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2a). Cell Death Differ (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4a). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 4c). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 7b
In order to elucidate the regulation and function of enzymatically inactive heparanase, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on rat samples (fig 7b). Cardiovasc Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3d
In order to report that cathepsin S inhibition sensitizes cancer cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 3d). Antioxid Redox Signal (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542S) was used in western blot on human samples at 1:1000 (fig 2c). Int J Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d
In order to examine the effects of curcumin treatment on myeloid leukemia cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 4d). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3c). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3c
In order to elucidate the role of HAP40 in Huntington's disease, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 3c). Mol Neurobiol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s5c
In order to identify and characterize an inhibitor of the COP9 signalosome, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s5c). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3a
In order to explore the role of the S100A7 in oral squamous cell carcinoma, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3a). Cancer Gene Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2d
In order to elucidate the contribution of MDM2 expression to retinoblastoma tumorigenesis, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 2d). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3a, 1e
  • western blot; mouse; loading ...; fig 1d, 3c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3a, 1e) and in western blot on mouse samples (fig 1d, 3c). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signalling, 9532) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532S) was used in western blot on human samples (fig 2c). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3f
In order to elucidate the upstream mechanisms of apoptosis triggered by an anti-microtubule drug, ABT-751, Cell Signaling Technology Parp1 antibody (cell signalling, 9542) was used in western blot on human samples at 1:1000 (fig 3f). Toxicol Appl Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples (fig 1a). Mol Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1e
Cell Signaling Technology Parp1 antibody (cell signalling, 9542) was used in western blot on human samples at 1:1000 (fig 1e). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7h
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7h). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 2
In order to elucidate the mechanisms by which mutant IDH1/2 contributes to oncogenesis, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3h
In order to elucidate how FADD contributes to mitochondrial-associated apoptosis, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542P) was used in western blot on human samples at 1:1000 (fig 3h). Mol Cell Biochem (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s2i
In order to discover that ubiquitin-specific protease 7 is a regulator of N-Myc function in neuroblastoma, Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples at 1:1000 (fig s2i). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5b). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 9c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on rat samples at 1:1000 (fig 9c). J Pharmacol Exp Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5B
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5B). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3c
In order to test if focal adhesion kinase present in rhabdomyosarcoma affect cellular survival, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3c). Transl Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
In order to test if focal adhesion kinase present in rhabdomyosarcoma affect cellular survival, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3c). Transl Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3f
In order to report that inhibition of PP2A kills PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3f). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 4b). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s15
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s15). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1d). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b,5c,6b,6c,6d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 8a
In order to assess the anticancer properties of 3',4',5'-trimethoxy-5-chloro-isatinylchalcone, Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 8a). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5F
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5F). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 4a
In order to discover and characterize beta-cell protective agents that prevent endoplasmic reticulum stress-induced dysfunction and death, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542L) was used in western blot on rat samples at 1:1000 (fig 4a). J Med Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; dogs; 1:1000; fig 3a
In order to investigate how serine proteases increase transepithelial electrical resistance, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on dogs samples at 1:1000 (fig 3a). Am J Physiol Gastrointest Liver Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 1
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:500 (fig 1). Cell Div (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Parp1 antibody (CST, 9542) was used in western blot on human samples at 1:1000 (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 6). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5d
In order to study how methylation of p53 affects its interactions with other proteins such as PUMA and p300/CBP, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 5d). Oncogene (2017) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5g
Cell Signaling Technology Parp1 antibody (cell signalling, 9532) was used in western blot on human samples (fig 5g). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
In order to research differentiation of functional glutamatergic neurons from placenta-derived multipotent cells by knocking down of heat-shock protein 27, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on mouse samples (fig 1). Mol Cancer Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4c
In order to examine the role of topoisomerase II in mitotic clonal expansion and adipogenesis, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 4c). Cell Signal (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling Tech, 9532 S) was used in western blot on human samples (fig 3). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 3f). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 5e
In order to examine how Stat5a modulation affects breast cancer cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:500 (fig 5e). Mol Cancer Res (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 3). Exp Ther Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig 5c). J Transl Med (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 4
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4
Cell Signaling Technology Parp1 antibody (CST, 9532) was used in western blot on human samples (fig 4). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 1
  • immunohistochemistry; human; fig 1
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in immunocytochemistry on human samples (fig 1), in immunohistochemistry on human samples (fig 1) and in western blot on human samples (fig 1). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 1). Int J Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s3b
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples (fig s3b) and in western blot on human samples (fig 2c). Carcinogenesis (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1). J Ovarian Res (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 7
In order to study promotion of survival of breast cancer cells in response to hyper-fractionated radiation treatment by RAC1 GTPase, Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 7). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; loading ...; fig 4e
In order to investigate the role of autophagy in the anti-neurotoxicity effect of resveratrol, Cell Signaling Technology Parp1 antibody (Cell signaling, 9532S) was used in western blot on rat samples (fig 4e). Neurochem Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3h
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3h). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6
In order to determine the promotion of genomic and phenotypic changes in glioblastoma cells by temozolomide, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6). Cancer Cell Int (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 9
Cell Signaling Technology Parp1 antibody (Cell Signaling Tech, 9542) was used in western blot on human samples at 1:1000 (fig 9). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). BMC Complement Altern Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 4). Breast Cancer Res Treat (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
In order to study regulation of repair of DNA double-strand breaks in triple-negative breast cancer by long noncoding RNA LINP1, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1). Nat Struct Mol Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 2b
In order to determine the functional significance of miR-145-3p and bladder cancer oncogenic pathways, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:500 (fig 2b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s5
In order to investigate the consequences of genetic or pharmacological inhibition of BMI1, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig s5). Autophagy (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). Int J Oncol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7a). Oncol Rep (2016) ncbi
domestic rabbit monoclonal (46D11)
  • reverse phase protein lysate microarray; mouse; fig s1.b,c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in reverse phase protein lysate microarray on mouse samples (fig s1.b,c). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 7
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples at 1:2000 (fig 7). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; loading ...; fig 5b
In order to study the effects of a HDAC 3-selective inhibitor, RGFP966, on NF-kB and histones, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:1000 (fig 5b). Biochem Pharmacol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4f
In order to show how FADD regulates NF-kappaB activation and promotes ubiquitination of cFLIPL, which induces apoptosis, Cell Signaling Technology Parp1 antibody (Cell signaling technology, 9542P) was used in western blot on human samples at 1:1000 (fig 4f). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:1000; fig s5
In order to characterize how mitochondrial Ca(21) uptake through MICU1 regulation dictates tissue regeneration and survival, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on mouse samples at 1:1000 (fig s5). Nat Commun (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling Technolog, 9532) was used in western blot on mouse samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6b
Cell Signaling Technology Parp1 antibody (cell signalling, 9542) was used in western blot on human samples (fig 6b). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
In order to characterize multiple molecularly defined cancer indications by studying ROS1, ALK inhibitor, Entrectinib, a Pan-TRK activity, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2). Mol Cancer Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3f). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (cell Signaling Tech, 9542 S) was used in western blot on human samples (fig 3). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to study increased dissociation of hexokinase II from mitochondrial outer membrane by overexpression or ErbB2 rendering breast cancer cells susceptible to 3-BrPA, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling Tech, 9542S) was used in western blot on human samples (fig 3). Sci Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s3). Int J Biochem Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; fig 1
In order to determine regulation of global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha by the small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives, Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on rat samples (fig 1). Cell Stress Chaperones (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4f
In order to study the role of PHF8 during mesodermal and cardiac lineage commitment using mouse embryonic stem cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on mouse samples at 1:1000 (fig 4f). Stem Cells (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, cst-9532) was used in western blot on human samples at 1:1000 (fig 3). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
In order to study quinacrine-induced apoptosis, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6d). Biochem Pharmacol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to investigate proteolytic processing of p27, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:2000; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:2000 (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s8
In order to evaluate the differential responses to H3N2 influenza virus infection in vitro in human nasal epithelial cells derived from multiple subjects, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig s8). J Allergy Clin Immunol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 2). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s1
In order to analyze delay of neurodegeneration by preventing stress-induced OPA1 processing in mitochondria by loss of OMA1, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on mouse samples (fig s1). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (46D11)
  • immunoprecipitation; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in immunoprecipitation on human samples (fig 3). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology Parp1 antibody (Cell signalling, 9542) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542S) was used in western blot on human samples (fig 2c). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig s5
In order to investigate the role of FOXO1 in vascular growth, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig s5). Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 1). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 5
Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; fig 1
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in immunoprecipitation on mouse samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology Parp1 antibody (Cell Signalling, 9542) was used in western blot on human samples (fig 5). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 7). Nucleic Acids Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 2
In order to report the mechanism by which imiquimod induces apoptosis in melanoma cells, Cell Signaling Technology Parp1 antibody (Cell Signalling Technology, 9542) was used in western blot on human samples at 1:500 (fig 2). J Cell Mol Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 2i
In order to assess the definition of obligate participation in multiple hallmarks of cancer by a comprehensive functional characterization of cancer-testis antigens, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000 (fig 2i). Nat Commun (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples at 1:1000 (fig 2d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 9e
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 9e). J Virol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 2
In order to characterize inhibition of gamma-irradiation-induced apoptosis of prostate cancer cells by elevated expression of hepatoma up-regulated protein, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples at 1:500 (fig 2). J Cell Biochem (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology Parp1 antibody (cell signalling, 9532) was used in western blot on human samples (fig 3c). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9545) was used in western blot on rat samples (fig 2). Cell Death Differ (2016) ncbi
domestic rabbit monoclonal (46D11)
  • other; human; fig 1
  • immunocytochemistry; human; fig 1
In order to study the involvement of TIMELESS in the PARP1-mediated DNA damage response, Cell Signaling Technology Parp1 antibody (Cell Signalling, 46D11) was used in other on human samples (fig 1) and in immunocytochemistry on human samples (fig 1). Cell Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; fig 5h
In order to study the relationship between arginine methylation and ubiquitylation in carcinogenesis and KLF4-mediated stability, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 5h). Nat Commun (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s4f
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig s4f). Nature (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:300; fig 6d
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:300 (fig 6d). FEBS Open Bio (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6b
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on human samples (fig 6b). Neuroendocrinology (2016) ncbi
domestic rabbit polyclonal
  • western blot; human
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9545) was used in western blot on human samples . Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1k
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 1k). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples (fig 3). Leukemia (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
Cell Signaling Technology Parp1 antibody (Cell Signaling Tech, 9532) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; 1:2000
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples at 1:2000. Mol Oncol (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling Tech, 9532) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to analyze protection of urothelial cell carcinoma from treatment-induced DNA damage via YAP activation, Cell Signaling Technology Parp1 antibody (Cell signaling, 9542) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; 1:1000; fig 4
In order to elucidate ketamine-induced ulcerative cystitis and bladder apoptosis in association with oxidative stress mediated by mitochondria and the endoplasmic reticulum, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on rat samples at 1:1000 (fig 4). Am J Physiol Renal Physiol (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 2). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:250; fig 4c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:250 (fig 4c). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig s3). Cell Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig s2a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig s2a). Sci Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to investigate how RIG-I-like receptors prevent cancer, Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 3). Cell Death Dis (2015) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 1c
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9542) was used in western blot on rat samples (fig 1c). Mol Neurobiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 9c
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9542) was used in western blot on human samples (fig 9c). Autophagy (2016) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 1f, 2a, 4h
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples (fig 1f, 2a, 4h). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 6
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig 6). PLoS Pathog (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 5d
In order to study the role of STAT3 in KRAS mutant lung adenocarcinoma., Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples (fig 5d). Nat Commun (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig s4
Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples (fig s4). Nat Neurosci (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 2
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532S) was used in western blot on mouse samples (fig 2). DNA Repair (Amst) (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 5a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 5a). Cancer Lett (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig s3
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s3). Cancer Discov (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532 s) was used in western blot on human samples at 1:1000. J Exp Clin Cancer Res (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 1
Cell Signaling Technology Parp1 antibody (Cell signaling, 9532) was used in western blot on human samples (fig 1). J Cereb Blood Flow Metab (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000; loading ...; fig 1A
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples at 1:1000 (fig 1A). Mol Med Rep (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
In order to identify PITX1 as a key specificity factor for HIF-1alpha dependent gene expression, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Cell Cycle (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; rat; fig 1f
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on rat samples (fig 1f). J Biol Chem (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000. Cancer Lett (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples at 1:1000. Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig s1
  • western blot; rat; fig 1
In order to elucidate both MTP-dependent and -independent roles of PDI1, Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on mouse samples (fig s1) and in western blot on rat samples (fig 1). Mol Biol Cell (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
In order to investigate the use of paradox-breaking pan-RAF inhibitors to treat cancer, Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples . Cancer Cell (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; loading ...; fig 4D
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 4D). Oncotarget (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse; fig 10e
In order to identify DUBA as a suppressor of IL-17 production in T cells, Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on mouse samples (fig 10e). Nature (2015) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples . Cell Death Dis (2014) ncbi
domestic rabbit monoclonal (46D11)
  • immunoprecipitation; human; fig 4a
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in immunoprecipitation on human samples (fig 4a). Cell Rep (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples . Gynecol Oncol (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 3
In order to study reprogramming of cells toward a metastatic-like state by p53 psi, a transcriptionally inactive p53 isoform, Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples (fig 3). Proc Natl Acad Sci U S A (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 9532) was used in western blot on human samples . Cell Death Differ (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; 1:1000
Cell Signaling Technology Parp1 antibody (Cell Signaling, 46D11) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; mouse
Cell Signaling Technology Parp1 antibody (Cell Signaling Technology, 46D11) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (46D11)
  • western blot; human; fig 6
Cell Signaling Technology Parp1 antibody (Cell Signaling, 9532) was used in western blot on human samples (fig 6). Free Radic Biol Med (2014) ncbi
BD Biosciences
mouse monoclonal (42/PARP)
  • western blot; human; loading ...; fig 3c
In order to investigate the contribution of PINK1 and PARKIN to cell death, BD Biosciences Parp1 antibody (BD Biosciences, 42/PARP) was used in western blot on human samples (fig 3c). J Biol Chem (2016) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
In order to study CaeB-mediated apoptosis, BD Biosciences Parp1 antibody (BD Bioscience, 611038) was used in western blot on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
BD Biosciences Parp1 antibody (BD Biosciences, 611038) was used in western blot on human samples . Biol Pharm Bull (2014) ncbi
mouse monoclonal (42/PARP)
  • western blot; human
BD Biosciences Parp1 antibody (BD, 611038) was used in western blot on human samples . Cell (2014) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1b
  • western blot; human; loading ...; fig 1f
MilliporeSigma Parp1 antibody (Sigma, AV33754) was used in western blot on mouse samples (fig 1b) and in western blot on human samples (fig 1f). Redox Biol (2021) ncbi
mouse monoclonal (C-2-10)
  • western blot; human; 1:1000; fig 4
MilliporeSigma Parp1 antibody (Sigma, P248) was used in western blot on human samples at 1:1000 (fig 4). Front Microbiol (2015) ncbi
Articles Reviewed
  1. Carroll P, Freie B, Cheng P, Kasinathan S, Gu H, Hedrich T, et al. The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis. PLoS Biol. 2021;19:e3001085 pubmed publisher
  2. Yadav A, Huang T, Chen S, Ramasamy T, Hsueh Y, Lin S, et al. Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination. J Neuroinflammation. 2021;18:238 pubmed publisher
  3. Zhu X, Peng S, Wang L, Chen X, Feng C, Liu Y, et al. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Cell Death Dis. 2021;12:918 pubmed publisher
  4. Zhao H, Tang J, Chen H, Gu W, Geng H, Wang L, et al. 14,15-EET Reduced Brain Injury from Cerebral Ischemia and Reperfusion via Suppressing Neuronal Parthanatos. Int J Mol Sci. 2021;22: pubmed publisher
  5. Chiang C, Hong Y. In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy. Sci Rep. 2021;11:18172 pubmed publisher
  6. Chen Y, Li J, Menon R, Jayaraman A, Lee K, Huang Y, et al. Dietary spinach reshapes the gut microbiome in an Apc-mutant genetic background: mechanistic insights from integrated multi-omics. Gut Microbes. 2021;13:1972756 pubmed publisher
  7. Keane L, Cheray M, Saidi D, Kirby C, Friess L, González Rodríguez P, et al. Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas. Neurooncol Adv. 2021;3:vdab096 pubmed publisher
  8. Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson M, Schmitz W, Wach S, et al. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 2021;12:5066 pubmed publisher
  9. Sánchez Fdez A, Re Louhau M, Rodríguez Núñez P, Ludeña D, Matilla Almazán S, Pandiella A, et al. Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer. NPJ Precis Oncol. 2021;5:78 pubmed publisher
  10. Yuan T, Annamalai K, Naik S, Lupse B, Geravandi S, Pal A, et al. The Hippo kinase LATS2 impairs pancreatic β-cell survival in diabetes through the mTORC1-autophagy axis. Nat Commun. 2021;12:4928 pubmed publisher
  11. Yan D, Li X, Yang Q, Huang Q, Yao L, Zhang P, et al. Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30. Cell Death Discov. 2021;7:211 pubmed publisher
  12. Wang Z, Guo M, Cui Q, Yuan H, Shan Ji Fu -, Liu B, et al. PARP1 deficiency protects against hyperglycemia-induced neointimal hyperplasia by upregulating TFPI2 activity in diabetic mice. Redox Biol. 2021;46:102084 pubmed publisher
  13. Kanellis D, Espinoza J, Zisi A, Sakkas E, Bartkova J, Katsori A, et al. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output. Sci Adv. 2021;7: pubmed publisher
  14. Lupse B, Annamalai K, Ibrahim H, Kaur S, Geravandi S, Sarma B, et al. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes. Cell Rep. 2021;36:109490 pubmed publisher
  15. Oiwa K, Hosono N, Nishi R, Scotto L, O Connor O, Yamauchi T. Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance. BMC Cancer. 2021;21:879 pubmed publisher
  16. Shen C, Hsieh C, Jiang K, Lin C, Chiang N, Li T, et al. AUY922 induces retinal toxicity through attenuating TRPM1. J Biomed Sci. 2021;28:55 pubmed publisher
  17. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed publisher
  18. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  19. Kim Y, Lee J, Kim H, Jang J, Choung Y. Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway. Int J Mol Sci. 2021;22: pubmed publisher
  20. Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat Commun. 2021;12:3651 pubmed publisher
  21. Yi J, Sias Garcia O, Nasholm N, Hu X, Iniguez A, Hall M, et al. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Neoplasia. 2021;23:624-633 pubmed publisher
  22. Williams H, Wadey K, Frankow A, Blythe H, Forbes T, Johnson J, et al. Aneurysm severity is suppressed by deletion of CCN4. J Cell Commun Signal. 2021;15:421-432 pubmed publisher
  23. Ma X, Zhao T, Yan H, Guo K, Liu Z, Wei L, et al. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell Death Dis. 2021;12:544 pubmed publisher
  24. Lee J, Hsu Y, Li Y, Cheng S. Galectin-3 Inhibitors Suppress Anoikis Resistance and Invasive Capacity in Thyroid Cancer Cells. Int J Endocrinol. 2021;2021:5583491 pubmed publisher
  25. Prokakis E, Dyas A, Grün R, Fritzsche S, Bedi U, Kazerouni Z, et al. USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene. 2021;40:4004-4018 pubmed publisher
  26. Bi Y, Chen X, Wei B, Wang L, Gong L, Li H, et al. DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells. Theranostics. 2021;11:6355-6369 pubmed publisher
  27. Gusyatiner O, Bady P, Pham M, Lei Y, Park J, Daniel R, et al. BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma. Neuro Oncol. 2021;23:1680-1692 pubmed publisher
  28. Cheng J, Duan X, Fu X, Jiang Y, Yang P, Cao C, et al. RIP1 Perturbation Induces Chondrocyte Necroptosis and Promotes Osteoarthritis Pathogenesis via Targeting BMP7. Front Cell Dev Biol. 2021;9:638382 pubmed publisher
  29. Supper E, Rudat S, Iyer V, Droop A, Wong K, Spinella J, et al. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia. Nat Commun. 2021;12:2482 pubmed publisher
  30. Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, et al. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis. 2021;12:425 pubmed publisher
  31. Xue Y, Wang S, Rana P, West E, Hong C, Feng H, et al. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa. elife. 2021;10: pubmed publisher
  32. Andrade J, Shi C, Costa A, Choi J, Kim J, Doddaballapur A, et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat Cell Biol. 2021;23:413-423 pubmed publisher
  33. Ditano J, Donahue K, Tafe L, McCleery C, Eastman A. Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction. Sci Rep. 2021;11:7077 pubmed publisher
  34. Kamata T, Yang C, Melhuish T, Frierson H, Wotton D, Paschal B. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling. Cells. 2021;10: pubmed publisher
  35. Guo S, Chen Y, Yang Y, Zhang X, Ma L, Xue X, et al. TRIB2 modulates proteasome function to reduce ubiquitin stability and protect liver cancer cells against oxidative stress. Cell Death Dis. 2021;12:42 pubmed publisher
  36. Xiong M, Wu M, Dan Peng -, Huang W, Chen Z, Ke H, et al. LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells. Cell Death Dis. 2021;12:24 pubmed publisher
  37. He S, Ma X, Zheng N, Wang G, Wang M, Xia W, et al. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells. Mol Med Rep. 2021;23: pubmed publisher
  38. Riad A, Gitto S, Lee H, Winters H, Martorano P, Hsieh C, et al. PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response. Molecules. 2020;25: pubmed publisher
  39. Hewitt G, Borel V, Segura Bayona S, Takaki T, Ruis P, Bellelli R, et al. Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD. Mol Cell. 2020;: pubmed publisher
  40. Song M, YEKU O, Rafiq S, Purdon T, Dong X, Zhu L, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11:6298 pubmed publisher
  41. Carullo G, Mazzotta S, Koch A, Hartmann K, Friedrich O, Gilbert D, et al. New Oleoyl Hybrids of Natural Antioxidants: Synthesis and In Vitro Evaluation as Inducers of Apoptosis in Colorectal Cancer Cells. Antioxidants (Basel). 2020;9: pubmed publisher
  42. Omairi I, Kobeissy F, Nasreddine S. Anti-Oxidant, Anti-Hemolytic Effects of Crataegus aronia Leaves and Its Anti- Proliferative Effect Enhance Cisplatin Cytotoxicity in A549 Human Lung Cancer Cell Line. Asian Pac J Cancer Prev. 2020;21:2993-3003 pubmed publisher
  43. Lomphithak T, Choksi S, Mutirangura A, Tohtong R, Tencomnao T, Usubuchi H, et al. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma. Cell Commun Signal. 2020;18:161 pubmed publisher
  44. Moses N, Zhang M, Wu J, Hu C, Xiang S, Geng X, et al. HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1. Cells. 2020;9: pubmed publisher
  45. Cheng C, Wooten J, Gibbs Z, McGlynn K, Mishra P, Whitehurst A. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma. elife. 2020;9: pubmed publisher
  46. Tan Y, Sementino E, Liu Z, Cai K, Testa J. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis. Sci Rep. 2020;10:15837 pubmed publisher
  47. He S, Fang X, Xia X, Hou T, Zhang T. Targeting CDK9: A novel biomarker in the treatment of endometrial cancer. Oncol Rep. 2020;44:1929-1938 pubmed publisher
  48. González Rodríguez P, Cheray M, Füllgrabe J, Salli M, Engskog Vlachos P, Keane L, et al. The DNA methyltransferase DNMT3A contributes to autophagy long-term memory. Autophagy. 2020;:1-19 pubmed publisher
  49. Lim C, Or Y, Ong Z, Chung H, Hayashi H, Shrestha S, et al. Estrogen exacerbates mammary involution through neutrophil-dependent and -independent mechanism. elife. 2020;9: pubmed publisher
  50. Nassar Z, Mah C, Dehairs J, Burvenich I, Irani S, Centenera M, et al. Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. elife. 2020;9: pubmed publisher
  51. Gu J, Zhang Y, Wang X, Xiang J, Deng S, Wu D, et al. Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway. BMC Complement Med Ther. 2020;20:214 pubmed publisher
  52. Zhang H, Qi L, Du Y, Huang L, Braun F, Kogiso M, et al. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma. Cancers (Basel). 2020;12: pubmed publisher
  53. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed publisher
  54. Feng Y, Mischler W, Gurung A, Kavanagh T, Androsov G, Sadow P, et al. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. Cancer Res. 2020;80:2751-2763 pubmed publisher
  55. Xu W, Wu H, Chen S, Wang X, Tanaka S, Sugiyama K, et al. Cytotoxic effects of vitamins K1, K2 and K3 against human T lymphoblastoid leukemia cells through apoptosis induction and cell cycle arrest. Chem Biol Drug Des. 2020;: pubmed publisher
  56. Wu P, Hong S, Starenki D, Oshima K, Shao H, Gestwicki J, et al. Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Oncogene. 2020;39:4257-4270 pubmed publisher
  57. Han B, Meng X, Wu P, Li Z, Li S, Zhang Y, et al. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma. Theranostics. 2020;10:3351-3365 pubmed publisher
  58. Zhang J, Huang J, Zhang Y, Zhang X, Zhao L, Li C, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine. 2020;53:102701 pubmed publisher
  59. Reynders M, Matsuura B, Bérouti M, Simoneschi D, Marzio A, Pagano M, et al. PHOTACs enable optical control of protein degradation. Sci Adv. 2020;6:eaay5064 pubmed publisher
  60. Howell M, Green R, Khalil R, Foran E, Quarni W, Nair R, et al. Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis. FASEB Bioadv. 2020;2:90-105 pubmed publisher
  61. Pothuraju R, Rachagani S, Krishn S, Chaudhary S, Nimmakayala R, Siddiqui J, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020;19:37 pubmed publisher
  62. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed publisher
  63. Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, et al. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer. 2020;19:28 pubmed publisher
  64. Li K, Zhao S, Long J, Su J, Wu L, Tao J, et al. A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products. Cancer Cell Int. 2020;20:36 pubmed publisher
  65. Jiang L, Xu K, Li J, Zhou X, Xu L, Wu Z, et al. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats. Aging (Albany NY). 2020;12:1760-1777 pubmed publisher
  66. Li T, Li K, Zhang S, Wang Y, Xu Y, Cronin S, et al. Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice. Cell Death Dis. 2020;11:77 pubmed publisher
  67. Qiao H, Tan X, Lv D, Xing R, Shu F, Zhong C, et al. Phosphoribosyl pyrophosphate synthetases 2 knockdown inhibits prostate cancer progression by suppressing cell cycle and inducing cell apoptosis. J Cancer. 2020;11:1027-1037 pubmed publisher
  68. Aldaz P, Otaegi Ugartemendia M, Sáenz Antoñanzas A, Garcia Puga M, Moreno Valladares M, Flores J, et al. SOX9 promotes tumor progression through the axis BMI1-p21CIP. Sci Rep. 2020;10:357 pubmed publisher
  69. Liu Q, Borcherding N, Shao P, Maina P, Zhang W, Qi H. Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. EBioMedicine. 2020;51:102612 pubmed publisher
  70. Ding L, Zhu Q, Zhou F, Tan H, Xu W, Pan C, et al. Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma. PLoS Pathog. 2019;15:e1008174 pubmed publisher
  71. Santos Barriopedro I, Li Y, Bahl S, Seto E. HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1. Genes Cancer. 2019;10:119-133 pubmed publisher
  72. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  73. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed publisher
  74. Yukawa M, Jagannathan S, Vallabh S, Kartashov A, Chen X, Weirauch M, et al. AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation. J Exp Med. 2020;217: pubmed publisher
  75. Jung J, Lee H, Cao B, Liao P, Zeng S, Lu H. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 2019;: pubmed publisher
  76. Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed publisher
  77. Han Y, Wang Z, Sun S, Zhang Z, Liu J, Jin X, et al. Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer. Epigenetics. 2019;:1-12 pubmed publisher
  78. Basturk O, Weigelt B, Adsay V, Benhamida J, Askan G, Wang L, et al. Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity. Mod Pathol. 2020;33:456-467 pubmed publisher
  79. Guan J, Zhou W, Hafner M, Blake R, Chalouni C, Chen I, et al. Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility. Cell. 2019;178:949-963.e18 pubmed publisher
  80. Sin Chan P, Mumal I, Suwal T, Ho B, Fan X, Singh I, et al. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor. Cancer Cell. 2019;36:51-67.e7 pubmed publisher
  81. Tacconi E, Badie S, De Gregoriis G, Reisländer T, Lai X, Porru M, et al. Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance. EMBO Mol Med. 2019;11:e9982 pubmed publisher
  82. Kaur S, Nag A, Gangenahalli G, Sharma K. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Front Genet. 2019;10:554 pubmed publisher
  83. Wang R, Geng J, Sheng W, Liu X, Jiang M, Zhen Y. The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation. Cancer Cell Int. 2019;19:145 pubmed publisher
  84. Pietila M, Sahgal P, Peuhu E, Jäntti N, Paatero I, Närvä E, et al. SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nat Commun. 2019;10:2340 pubmed publisher
  85. Bentz G, Lowrey A, Horne D, Nguyen V, Satterfield A, Ross T, et al. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. PLoS ONE. 2019;14:e0217578 pubmed publisher
  86. Wu K, Zou J, Lin C, Jie Z. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling. Biosci Rep. 2019;: pubmed publisher
  87. Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song Y, et al. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38:184 pubmed publisher
  88. Hernández Alvarez M, Sebastian D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, et al. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell. 2019;177:881-895.e17 pubmed publisher
  89. Shi K, Yin X, Cai M, Yan Y, Jia C, Ma P, et al. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors. elife. 2019;8: pubmed publisher
  90. Chung H, Zou X, Bajar B, Brand V, Huo Y, Alcudia J, et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science. 2019;364: pubmed publisher
  91. Song T, Spillmann D. Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells. J Cell Mol Med. 2019;23:4559-4568 pubmed publisher
  92. Singh R, Peng S, Viswanath P, Sambandam V, Shen L, Rao X, et al. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis. EMBO Mol Med. 2019;: pubmed publisher
  93. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  94. Liu X, Chen H, Hou Y, Ma X, Ye M, Huang R, et al. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway. Int J Oncol. 2019;54:1466-1480 pubmed publisher
  95. Chen M, Du Y, Sun L, Hsu J, Wang Y, Gao Y, et al. H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism. J Biol Chem. 2019;294:8516-8528 pubmed publisher
  96. Luo H, Jing B, Xia Y, Zhang Y, Hu M, Cai H, et al. WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell Int. 2019;19:56 pubmed publisher
  97. Gennaro V, Wedegaertner H, McMahon S. Interaction between the BAG1S isoform and HSP70 mediates the stability of anti-apoptotic proteins and the survival of osteosarcoma cells expressing oncogenic MYC. BMC Cancer. 2019;19:258 pubmed publisher
  98. Liu Z, Mar K, Hanners N, Perelman S, Kanchwala M, Xing C, et al. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. Nature. 2019;: pubmed publisher
  99. Park H, Chung K, An H, Gim J, Hong J, Woo H, et al. Parkin Promotes Mitophagic Cell Death in Adult Hippocampal Neural Stem Cells Following Insulin Withdrawal. Front Mol Neurosci. 2019;12:46 pubmed publisher
  100. Greer Y, Gilbert S, Gril B, Narwal R, Peacock Brooks D, Tice D, et al. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Res. 2019;21:27 pubmed publisher
  101. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed publisher
  102. Nassour J, Radford R, Correia A, Fusté J, Schoell B, Jauch A, et al. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659-663 pubmed publisher
  103. Yuan Z, Zhang H, Hasnat M, Ding J, Chen X, Liang P, et al. A new perspective of triptolide-associated hepatotoxicity: Liver hypersensitivity upon LPS stimulation. Toxicology. 2019;414:45-56 pubmed publisher
  104. Park B, Chang S, Lee G, Kang B, Kim J, Park H. Wnt3a disrupts GR-TEAD4-PPARγ2 positive circuits and cytoskeletal rearrangement in a β-catenin-dependent manner during early adipogenesis. Cell Death Dis. 2019;10:16 pubmed publisher
  105. Chen L, Yang G, Dong H. Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway. Med Sci Monit. 2019;25:77-86 pubmed publisher
  106. Zhao Z, Wang L, Volk A, Birch N, Stoltz K, Bartom E, et al. Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia. Genes Dev. 2019;33:61-74 pubmed publisher
  107. Xie Y, Fan H, Lu W, Yang Q, Nurkesh A, Yeleussizov T, et al. Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene. 2019;38:2967-2983 pubmed publisher
  108. Pan W, Moroishi T, Koo J, Guan K. Cell type-dependent function of LATS1/2 in cancer cell growth. Oncogene. 2019;38:2595-2610 pubmed publisher
  109. Wu R, Li A, Sun B, Sun J, Zhang J, Zhang T, et al. A novel m6A reader Prrc2a controls oligodendroglial specification and myelination. Cell Res. 2019;29:23-41 pubmed publisher
  110. Jeon Y, Kim T, Park D, Nuovo G, Rhee S, Joshi P, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nat Commun. 2018;9:5110 pubmed publisher
  111. Unni A, Harbourne B, Oh M, Wild S, Ferrarone J, Lockwood W, et al. Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells. elife. 2018;7: pubmed publisher
  112. Barreta A, Sarian L, Ferracini A, Costa L, Mazzola P, de Angelo Andrade L, et al. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Hum Pathol. 2019;85:72-81 pubmed publisher
  113. Serebryannyy L, Misteli T. HiPLA: High-throughput imaging proximity ligation assay. Methods. 2019;157:80-87 pubmed publisher
  114. Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181-1192 pubmed publisher
  115. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed publisher
  116. Jena K, Kolapalli S, Mehto S, Nath P, Das B, Sahoo P, et al. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy. EMBO J. 2018;37: pubmed publisher
  117. Tay L, Krishnan V, Sankar H, Chong Y, Chuang L, Tan T, et al. RUNX Poly(ADP-Ribosyl)ation and BLM Interaction Facilitate the Fanconi Anemia Pathway of DNA Repair. Cell Rep. 2018;24:1747-1755 pubmed publisher
  118. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  119. Lai C, Liu H, Tin K, Huang Y, Yeh K, Peng H, et al. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells. Oncogene. 2019;38:317-331 pubmed publisher
  120. Lin X, Cui M, Xu D, Hong D, Xia Y, Xu C, et al. Liver-specific deletion of Eva1a/Tmem166 aggravates acute liver injury by impairing autophagy. Cell Death Dis. 2018;9:768 pubmed publisher
  121. Johnson D, Taabazuing C, Okondo M, Chui A, Rao S, Brown F, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24:1151-1156 pubmed publisher
  122. Chhipa R, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, et al. AMP kinase promotes glioblastoma bioenergetics and tumour growth. Nat Cell Biol. 2018;20:823-835 pubmed publisher
  123. Lau A, Chung H, Komada T, Platnich J, Sandall C, Choudhury S, et al. Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest. 2018;128:2894-2913 pubmed publisher
  124. Roders N, Herr F, Ambroise G, Thaunat O, Portier A, Vazquez A, et al. SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production. Front Immunol. 2018;9:787 pubmed publisher
  125. Zhang X, Zhuang R, Wu H, Chen J, Wang F, Li G, et al. A novel role of endocan in alleviating LPS-induced acute lung injury. Life Sci. 2018;202:89-97 pubmed publisher
  126. Wang S, Liu A, Wu G, Ding H, Huang S, Nahman S, et al. The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation. Nat Commun. 2018;9:1234 pubmed publisher
  127. Qiang L, Wang J, Zhang Y, Ge P, Chai Q, Li B, et al. Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. Cell Mol Immunol. 2018;: pubmed publisher
  128. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed publisher
  129. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  130. Fu X, Zhang C, Meng H, Zhang K, Shi L, Cao C, et al. Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress. Cell Death Differ. 2018;25:1625-1637 pubmed publisher
  131. Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau D, Zavala E, et al. NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A. 2018;115:E1876-E1885 pubmed publisher
  132. Yin R, Guo L, Gu J, Li C, Zhang W. Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis. Int J Biochem Cell Biol. 2018;97:43-51 pubmed publisher
  133. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  134. Chung H, Calis J, Wu X, Sun T, Yu Y, Sarbanes S, et al. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell. 2018;172:811-824.e14 pubmed publisher
  135. Tan X, Banerjee P, Liu X, Yu J, Gibbons D, Wu P, et al. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018;128:1267-1282 pubmed publisher
  136. Margalef P, Kotsantis P, Borel V, Bellelli R, Panier S, Boulton S. Stabilization of Reversed Replication Forks by Telomerase Drives Telomere Catastrophe. Cell. 2018;172:439-453.e14 pubmed publisher
  137. Kline C, Ralff M, Lulla A, Wagner J, Abbosh P, Dicker D, et al. Role of Dopamine Receptors in the Anticancer Activity of ONC201. Neoplasia. 2018;20:80-91 pubmed publisher
  138. Shuang W, Hou L, Zhu Y, Li Q, Hu W. Mcl-1 stabilization confers resistance to taxol in human gastric cancer. Oncotarget. 2017;8:82981-82990 pubmed publisher
  139. Tracz Gaszewska Z, Klimczak M, Biecek P, Herok M, Kosiński M, Olszewski M, et al. Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation. Oncotarget. 2017;8:82123-82143 pubmed publisher
  140. Sagulenko V, Vitak N, Vajjhala P, Vince J, Stacey K. Caspase-1 Is an Apical Caspase Leading to Caspase-3 Cleavage in the AIM2 Inflammasome Response, Independent of Caspase-8. J Mol Biol. 2018;430:238-247 pubmed publisher
  141. Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman J. Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells. Oncotarget. 2017;8:72281-72301 pubmed publisher
  142. Paculova H, Kramara J, Simečková S, Fedr R, Soucek K, Hylse O, et al. BRCA1 or CDK12 loss sensitizes cells to CHK1 inhibitors. Tumour Biol. 2017;39:1010428317727479 pubmed publisher
  143. Miles M, Hawkins C. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death Dis. 2017;8:e3062 pubmed publisher
  144. Zhao Z, Jia Q, Wu M, Xie X, Wang Y, Song G, et al. Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation-Mediated Repression of the Hedgehog/Gli1 Pathway. Clin Cancer Res. 2018;24:130-144 pubmed publisher
  145. Xu Y, Wang Y, Yao A, Xu Z, Dou H, Shen S, et al. Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway. Sci Rep. 2017;7:11776 pubmed publisher
  146. Jiang X, Bao Y, Liu H, Kou X, Zhang Z, Sun F, et al. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene. 2017;36:6850-6862 pubmed publisher
  147. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  148. Chong I, Aronson L, Bryant H, Gulati A, Campbell J, Elliott R, et al. Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018;67:1780-1792 pubmed publisher
  149. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  150. Van T, Polykratis A, Straub B, Kondylis V, Papadopoulou N, Pasparakis M. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. J Clin Invest. 2017;127:2662-2677 pubmed publisher
  151. Shaffer S, Dunagin M, Torborg S, Torre E, Emert B, Krepler C, et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 2017;546:431-435 pubmed publisher
  152. Sinha S, Thomas D, Chan S, Gao Y, Brunen D, Torabi D, et al. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data. Nat Commun. 2017;8:15580 pubmed publisher
  153. Sykora P, Kanno S, Akbari M, Kulikowicz T, Baptiste B, Leandro G, et al. DNA Polymerase Beta Participates in Mitochondrial DNA Repair. Mol Cell Biol. 2017;37: pubmed publisher
  154. Kim J, Hu Z, Cai L, Li K, Choi E, Faubert B, et al. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Nature. 2017;546:168-172 pubmed publisher
  155. Jung J, Kim L, Wang X, Wu Q, Sanvoranart T, Hubert C, et al. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight. 2017;2: pubmed publisher
  156. Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, et al. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017;31:685-696.e6 pubmed publisher
  157. Yue X, Zuo Y, Ke H, Luo J, Lou L, Qin W, et al. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Biochem Pharmacol. 2017;137:29-50 pubmed publisher
  158. Liu Y, Chen X, Li J. Resveratrol protects against oxidized low‑density lipoprotein‑induced human umbilical vein endothelial cell apoptosis via inhibition of mitochondrial‑derived oxidative stress. Mol Med Rep. 2017;15:2457-2464 pubmed publisher
  159. Vivo M, Fontana R, Ranieri M, Capasso G, Angrisano T, Pollice A, et al. p14ARF interacts with the focal adhesion kinase and protects cells from anoikis. Oncogene. 2017;36:4913-4928 pubmed publisher
  160. Zhao H, Zhang L, Zhang Y, Zhao L, Wan Q, Wang B, et al. Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells. Oncotarget. 2017;8:36383-36398 pubmed publisher
  161. Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36:4778-4789 pubmed publisher
  162. Xiao Z, Gaertner S, Morresi Hauf A, Genzel R, Duell T, Ullrich A, et al. Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients. Neoplasia. 2017;19:385-395 pubmed publisher
  163. Zhang X, Fan J, Wang S, Li Y, Wang Y, Li S, et al. Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non-Small Cell Lung Cancer. Cancer Immunol Res. 2017;5:363-375 pubmed publisher
  164. Mehta N, Lyon J, Patil K, Mokarram N, Kim C, Bellamkonda R. Bacterial Carriers for Glioblastoma Therapy. Mol Ther Oncolytics. 2017;4:1-17 pubmed publisher
  165. Bhattacharya S, Srinivasan K, Abdisalaam S, Su F, Raj P, Dozmorov I, et al. RAD51 interconnects between DNA replication, DNA repair and immunity. Nucleic Acids Res. 2017;45:4590-4605 pubmed publisher
  166. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  167. Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44735 pubmed publisher
  168. Coni S, Mancuso A, Di Magno L, Sdruscia G, Manni S, Serrao S, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079 pubmed publisher
  169. Cho H, Um J, Lee J, Kim W, Kang W, Kim S, et al. ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes. Sci Rep. 2017;7:44186 pubmed publisher
  170. Kong P, Zhu X, Geng Q, Xia L, Sun X, Chen Y, et al. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Mol Ther. 2017;25:1027-1037 pubmed publisher
  171. Voráčová K, Hajek J, Mares J, Urajová P, Kuzma M, Cheel J, et al. The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells. PLoS ONE. 2017;12:e0172850 pubmed publisher
  172. Iurlaro R, Püschel F, León Annicchiarico C, O Connor H, Martin S, Palou Gramón D, et al. Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors. Mol Cell Biol. 2017;37: pubmed publisher
  173. Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O Neil N, et al. CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours. Nat Commun. 2017;8:14432 pubmed publisher
  174. Toots M, Männik A, Mumm K, Tämm K, Tamm T, Ustav E, et al. Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay. PLoS Pathog. 2017;13:e1006168 pubmed publisher
  175. Liu J, Wang Y, Song L, Zeng L, Yi W, Liu T, et al. A critical role of DDRGK1 in endoplasmic reticulum homoeostasis via regulation of IRE1α stability. Nat Commun. 2017;8:14186 pubmed publisher
  176. Cabukusta B, Kol M, Kneller L, Hilderink A, Bickert A, Mina J, et al. ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain. Sci Rep. 2017;7:41290 pubmed publisher
  177. Xu S, Yang Z, Fan Y, Guan B, Jia J, Gao Y, et al. Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53. Oncol Lett. 2016;12:4999-5006 pubmed publisher
  178. Chang V, Tsai Y, Tsai Y, Peng S, Chen S, Chang T, et al. Krüpple-like factor 10 regulates radio-sensitivity of pancreatic cancer via UV radiation resistance-associated gene. Radiother Oncol. 2017;122:476-484 pubmed publisher
  179. Aksoy P, Meneses P. The Role of DCT in HPV16 Infection of HaCaTs. PLoS ONE. 2017;12:e0170158 pubmed publisher
  180. Granato M, Rizzello C, Gilardini Montani M, Cuomo L, Vitillo M, Santarelli R, et al. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 2017;41:124-136 pubmed publisher
  181. Scott N, Rogers L, Prudova A, Brown N, Fortelny N, Overall C, et al. Interactome disassembly during apoptosis occurs independent of caspase cleavage. Mol Syst Biol. 2017;13:906 pubmed publisher
  182. Brasacchio D, Alsop A, Noori T, Lufti M, Iyer S, Simpson K, et al. Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization. Cell Death Differ. 2017;24:961-970 pubmed publisher
  183. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed publisher
  184. Dawar S, Lim Y, Puccini J, White M, Thomas P, Bouchier Hayes L, et al. Caspase-2-mediated cell death is required for deleting aneuploid cells. Oncogene. 2017;36:2704-2714 pubmed publisher
  185. Wang F, Jia J, Lal N, Zhang D, Chiu A, Wan A, et al. High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature. Cardiovasc Res. 2016;112:656-668 pubmed
  186. Chhabra A, Mukherji B, Batra D. Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53. Expert Opin Ther Targets. 2017;21:117-129 pubmed publisher
  187. Seo B, Min K, Woo S, Choe M, Choi K, Lee Y, et al. Inhibition of Cathepsin S Induces Mitochondrial ROS That Sensitizes TRAIL-Mediated Apoptosis Through p53-Mediated Downregulation of Bcl-2 and c-FLIP. Antioxid Redox Signal. 2017;27:215-233 pubmed publisher
  188. Morishita M, Kawamoto T, Hara H, Onishi Y, Ueha T, Minoda M, et al. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway. Int J Oncol. 2017;50:23-30 pubmed publisher
  189. Martínez Castillo M, Bonilla Moreno R, Alemán Lazarini L, Meraz Rios M, Orozco L, Cedillo Barron L, et al. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe. PLoS ONE. 2016;11:e0165971 pubmed publisher
  190. Park J, Lee C, Kim H, Kim D, Son J, Ko E, et al. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. Oncotarget. 2016;7:83308-83318 pubmed publisher
  191. Huang Z, Her L. The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity. Mol Neurobiol. 2017;54:7382-7400 pubmed publisher
  192. Schlierf A, Altmann E, Quancard J, Jefferson A, Assenberg R, Renatus M, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016;7:13166 pubmed publisher
  193. Dey K, Bharti R, Dey G, Pal I, Rajesh Y, Chavan S, et al. S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway. Cancer Gene Ther. 2016;23:382-391 pubmed publisher
  194. Fang Y, Kong Y, Xi J, Zhu M, Zhu T, Jiang T, et al. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity. Oncotarget. 2016;7:79327-79341 pubmed publisher
  195. Zhao X, Li L, Wang X, Fu R, Lv Y, Jin W, et al. Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0164752 pubmed publisher
  196. Shao X, Lai D, Zhang L, Xu H. Induction of Autophagy and Apoptosis via PI3K/AKT/TOR Pathways by Azadirachtin A in Spodoptera litura Cells. Sci Rep. 2016;6:35482 pubmed publisher
  197. Qi D, Cobrinik D. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation. Oncogene. 2017;36:1760-1769 pubmed publisher
  198. Choi Y, Shembade N, Parvatiyar K, Balachandran S, Harhaj E. TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS. Mol Cell Biol. 2017;37: pubmed publisher
  199. Alexander Savino C, Hayden M, Richardson C, Zhao J, Poligone B. Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells. Oncotarget. 2016;7:75954-75967 pubmed publisher
  200. Guan S, Zhao Y, Lu J, Yu Y, Sun W, Mao X, et al. Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis. Oncotarget. 2016;7:75914-75925 pubmed publisher
  201. Figueroa González G, García Castillo V, Coronel Hernández J, López Urrutia E, León Cabrera S, Arias Romero L, et al. Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer. J Cancer. 2016;7:1632-1644 pubmed
  202. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed publisher
  203. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed publisher
  204. Joo D, Tang Y, Blonska M, Jin J, Zhao X, Lin X. Regulation of Linear Ubiquitin Chain Assembly Complex by Caspase-Mediated Cleavage of RNF31. Mol Cell Biol. 2016;36:3010-3018 pubmed
  205. Ghorai A, Sarma A, Chowdhury P, Ghosh U. PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells. Radiat Oncol. 2016;11:126 pubmed
  206. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  207. Shi Y, Yu Y, Wang Z, Wang H, Bieerkehazhi S, Zhao Y, et al. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells. Oncotarget. 2016;7:73697-73710 pubmed publisher
  208. Zhang Q, Jin R, Zhang X, Sheng J, Yu F, Tan R, et al. The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment. Oncotarget. 2016;7:69688-69702 pubmed publisher
  209. Carbonneau M, M Gagné L, Lalonde M, Germain M, Motorina A, Guiot M, et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun. 2016;7:12700 pubmed publisher
  210. Ranjan K, Pathak C. Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death. Mol Cell Biochem. 2016;422:135-150 pubmed
  211. Tavana O, Li D, Dai C, Lopez G, Banerjee D, Kon N, et al. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med. 2016;22:1180-1186 pubmed publisher
  212. Liu T, Xiong J, Yi S, Zhang H, Zhou S, Gu L, et al. FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2. Oncogene. 2017;36:1678-1686 pubmed publisher
  213. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed publisher
  214. Olianas M, Dedoni S, Onali P. LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells. J Pharmacol Exp Ther. 2016;359:340-353 pubmed
  215. Edinger N, Lebendiker M, Klein S, Zigler M, Langut Y, Levitzki A. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF. PLoS ONE. 2016;11:e0162321 pubmed publisher
  216. Twardziok M, Kleinsimon S, Rolff J, Jäger S, Eggert A, Seifert G, et al. Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma. PLoS ONE. 2016;11:e0159749 pubmed publisher
  217. Jiao Z, Wu J, Liu C, Wen B, Zhao W, Du X. Nicotinic ?7 receptor inhibits the acylation stimulating protein?induced production of monocyte chemoattractant protein?1 and keratinocyte?derived chemokine in adipocytes by modulating the p38 kinase and nuclear factor??B signaling pathways. Mol Med Rep. 2016;14:2959-66 pubmed publisher
  218. Waters A, Stafman L, Garner E, Mruthyunjayappa S, Stewart J, Mroczek Musulman E, et al. Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells. Transl Oncol. 2016;9:263-73 pubmed publisher
  219. Cunningham C, Li S, Vizeacoumar F, Bhanumathy K, Lee J, Parameswaran S, et al. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016;7:61544-61561 pubmed publisher
  220. Oza J, Ganguly B, Kulkarni A, Ginjala V, Yao M, Ganesan S. A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response. J Biol Chem. 2016;291:22881-22893 pubmed
  221. Nakazawa S, Oikawa D, Ishii R, Ayaki T, Takahashi H, Takeda H, et al. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun. 2016;7:12547 pubmed publisher
  222. Nagano T, Nakano M, Nakashima A, Onishi K, Yamao S, Enari M, et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 2016;6:31758 pubmed publisher
  223. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed publisher
  224. Timucin A, Basaga H. SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights. PLoS ONE. 2016;11:e0161494 pubmed publisher
  225. Cao L, Zhang L, Zhao X, Zhang Y. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLoS ONE. 2016;11:e0161025 pubmed publisher
  226. Kang M, Park K, Yang J, Lee C, Oh S, Yun J, et al. miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. PLoS ONE. 2016;11:e0160961 pubmed publisher
  227. Duan H, Lee J, Moon S, Arora D, Li Y, Lim H, et al. Discovery, Synthesis, and Evaluation of 2,4-Diaminoquinazolines as a Novel Class of Pancreatic ?-Cell-Protective Agents against Endoplasmic Reticulum (ER) Stress. J Med Chem. 2016;59:7783-800 pubmed publisher
  228. Ronaghan N, Shang J, Iablokov V, Zaheer R, Colarusso P, Dion S, et al. The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction. Am J Physiol Gastrointest Liver Physiol. 2016;311:G466-79 pubmed publisher
  229. El Jamal S, Taylor E, Abd Elmageed Z, Alamodi A, Selimovic D, Alkhateeb A, et al. Interferon gamma-induced apoptosis of head and neck squamous cell carcinoma is connected to indoleamine-2,3-dioxygenase via mitochondrial and ER stress-associated pathways. Cell Div. 2016;11:11 pubmed publisher
  230. Anta B, Pérez Rodríguez A, Castro J, García Domínguez C, Ibiza S, Martínez N, et al. PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes. Cell Death Dis. 2016;7:e2311 pubmed publisher
  231. Liu M, Feng L, Sun P, Liu W, Wu W, Jiang B, et al. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice. PLoS ONE. 2016;11:e0159789 pubmed publisher
  232. Rada M, Vasileva E, Lezina L, Marouco D, Antonov A, Macip S, et al. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922-932 pubmed publisher
  233. Wu J, Lei H, Zhang J, Chen X, Tang C, Wang W, et al. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation. Oncotarget. 2016;7:58995-59005 pubmed publisher
  234. Cheng Y, Huang C, Lee Y, Tien L, Ku W, Chien R, et al. Knocking down of heat-shock protein 27 directs differentiation of functional glutamatergic neurons from placenta-derived multipotent cells. Sci Rep. 2016;6:30314 pubmed publisher
  235. Yan Y, Xie M, Zhang L, Zhou X, Xie H, Zhou L, et al. Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma. Onco Targets Ther. 2016;9:3925-37 pubmed publisher
  236. Jin H, Won M, Park S, Lee S, Park M, Bae J. FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells. PLoS ONE. 2016;11:e0159112 pubmed publisher
  237. Hogg S, Newbold A, Vervoort S, Cluse L, Martin B, Gregory G, et al. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members. Mol Cancer Ther. 2016;15:2030-41 pubmed publisher
  238. Jacobsen R, Mazloumi Gavgani F, Mellgren G, Lewis A. DNA Topoisomerase II? contributes to the early steps of adipogenesis in 3T3-L1 cells. Cell Signal. 2016;28:1593-603 pubmed publisher
  239. Chen Z, Wang Z, Pang J, Yu Y, Bieerkehazhi S, Lu J, et al. Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep. 2016;6:29090 pubmed publisher
  240. Heckler M, Zeleke T, Divekar S, Fernandez A, Tiek D, Woodrick J, et al. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer. Oncotarget. 2016;7:47201-47220 pubmed publisher
  241. Medler T, Craig J, Fiorillo A, Feeney Y, Harrell J, Clevenger C. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth. Mol Cancer Res. 2016;14:994-1008 pubmed
  242. Li Q, Guo Y, Chen F, Liu J, Jin P. Stromal cell-derived factor-1 promotes human adipose tissue-derived stem cell survival and chronic wound healing. Exp Ther Med. 2016;12:45-50 pubmed
  243. Shen J, Li Z, Li L, Lu L, Xiao Z, Wu W, et al. Vascular-targeted TNF? and IFN? inhibits orthotopic colorectal tumor growth. J Transl Med. 2016;14:187 pubmed publisher
  244. Akabane S, Matsuzaki K, Yamashita S, Arai K, Okatsu K, Kanki T, et al. Constitutive Activation of PINK1 Protein Leads to Proteasome-mediated and Non-apoptotic Cell Death Independently of Mitochondrial Autophagy. J Biol Chem. 2016;291:16162-74 pubmed publisher
  245. Hey F, Giblett S, Forrest S, Herbert C, Pritchard C. Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine. PLoS ONE. 2016;11:e0156877 pubmed publisher
  246. Raina K, Lu J, Qian Y, Altieri M, Gordon D, Rossi A, et al. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2016;113:7124-9 pubmed publisher
  247. Liu Z, Lam N, Wang E, Virden R, Pawel B, Attiyeh E, et al. Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma. Oncogene. 2017;36:97-109 pubmed publisher
  248. Andersen A, Flinck M, Oernbo E, Pedersen N, Viuff B, Pedersen S. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment. Mol Cancer. 2016;15:45 pubmed publisher
  249. Gilmore J, Sardiu M, Groppe B, Thornton J, Liu X, Dayebgadoh G, et al. WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. PLoS ONE. 2016;11:e0155492 pubmed publisher
  250. Huang Y, Yang X, Xu T, Kong Q, Zhang Y, Shen Y, et al. Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs. Int J Oncol. 2016;49:153-63 pubmed publisher
  251. Sun F, Zhang Z, Tan E, Lim Z, Li Y, Wang X, et al. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice. Carcinogenesis. 2016;37:701-711 pubmed publisher
  252. Yalon M, Tuval Kochen L, Castel D, Moshe I, Mazal I, Cohen O, et al. Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations. PLoS ONE. 2016;11:e0155711 pubmed publisher
  253. Ribeiro J, Schorl C, Yano N, Romano N, Kim K, Singh R, et al. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. J Ovarian Res. 2016;9:28 pubmed publisher
  254. Hein A, Post C, Sheinin Y, Lakshmanan I, Natarajan A, Enke C, et al. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. 2016;35:6319-6329 pubmed publisher
  255. Deng H, Mi M. Resveratrol Attenuates A?25-35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway. Neurochem Res. 2016;41:2367-79 pubmed publisher
  256. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  257. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed publisher
  258. Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao X, et al. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 2016;12:1129-52 pubmed publisher
  259. Stepanenko A, Andreieva S, Korets K, Mykytenko D, Baklaushev V, Huleyuk N, et al. Temozolomide promotes genomic and phenotypic changes in glioblastoma cells. Cancer Cell Int. 2016;16:36 pubmed publisher
  260. Rosiak K, Smolarz M, Stec W, Peciak J, Grzela D, Winiecka Klimek M, et al. IDH1R132H in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis. PLoS ONE. 2016;11:e0154726 pubmed publisher
  261. Strappazzon F, Di Rita A, Cianfanelli V, D Orazio M, Nazio F, Fimia G, et al. Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy. 2016;12:963-75 pubmed publisher
  262. Choi H, Kim M, Choi Y, Shin Y, Cho S, Ko S. Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation. BMC Complement Altern Med. 2016;16:122 pubmed publisher
  263. Du R, Liu Z, Hou X, Fu G, An N, Wang L. Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells. Mol Med Rep. 2016;13:5045-52 pubmed publisher
  264. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  265. Zhang Y, He Q, Hu Z, Feng Y, Fan L, Tang Z, et al. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nat Struct Mol Biol. 2016;23:522-30 pubmed publisher
  266. Song J, Wang Y, Teng M, Zhang S, Yin M, Lu J, et al. Cordyceps militaris induces tumor cell death via the caspase?dependent mitochondrial pathway in HepG2 and MCF?7 cells. Mol Med Rep. 2016;13:5132-40 pubmed publisher
  267. Zeng W, Liu Q, Chen Z, Wu X, Zhong Y, Wu J. Silencing of hERG1 Gene Inhibits Proliferation and Invasion, and Induces Apoptosis in Human Osteosarcoma Cells by Targeting the NF-?B Pathway. J Cancer. 2016;7:746-57 pubmed publisher
  268. Matsushita R, Yoshino H, Enokida H, Goto Y, Miyamoto K, Yonemori M, et al. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness. Oncotarget. 2016;7:28460-87 pubmed publisher
  269. Hall A, Lu W, Godfrey J, Antonov A, Paicu C, Moxon S, et al. The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration. Cell Death Dis. 2016;7:e2184 pubmed publisher
  270. Dey A, Mustafi S, Saha S, Kumar Dhar Dwivedi S, Mukherjee P, Bhattacharya R. Inhibition of BMI1 induces autophagy-mediated necroptosis. Autophagy. 2016;12:659-70 pubmed publisher
  271. Kwon S, Grisan V, Jang B, Herbert J, Badenhorst P. Genome-Wide Mapping Targets of the Metazoan Chromatin Remodeling Factor NURF Reveals Nucleosome Remodeling at Enhancers, Core Promoters and Gene Insulators. PLoS Genet. 2016;12:e1005969 pubmed publisher
  272. Slørdahl T, Abdollahi P, Vandsemb E, Rampa C, Misund K, Baranowska K, et al. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells. Oncotarget. 2016;7:27295-306 pubmed publisher
  273. Li C, Jung S, Yang Y, Kim K, Lim J, Cheon C, et al. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines. Int J Oncol. 2016;48:2639-46 pubmed publisher
  274. Sumiyoshi H, Matsushita A, Nakamura Y, Matsuda Y, Ishiwata T, Naito Z, et al. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Oncol Rep. 2016;35:3216-26 pubmed publisher
  275. Garcia C, Videla Richardson G, Dimopoulos N, Fernandez Espinosa D, Miriuka S, Sevlever G, et al. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199. PLoS ONE. 2016;11:e0152607 pubmed publisher
  276. Gruosso T, Mieulet V, Cardon M, Bourachot B, Kieffer Y, Devun F, et al. Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. EMBO Mol Med. 2016;8:527-49 pubmed publisher
  277. Liu X, Xiao Z, Han L, Zhang J, Lee S, Wang W, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18:431-42 pubmed publisher
  278. Leus N, van der Wouden P, van den Bosch T, Hooghiemstra W, Ourailidou M, Kistemaker L, et al. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol. 2016;108:58-74 pubmed publisher
  279. Ranjan K, Pathak C. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 2016;6:22787 pubmed publisher
  280. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed publisher
  281. Antony A, Paillard M, Moffat C, Juskeviciute E, Correnti J, Bolon B, et al. MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue regeneration. Nat Commun. 2016;7:10955 pubmed publisher
  282. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  283. Rai R, Chen Y, Lei M, Chang S. TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions. Nat Commun. 2016;7:10881 pubmed publisher
  284. Kemp M, Sancar A. ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress. J Biol Chem. 2016;291:9330-42 pubmed publisher
  285. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed publisher
  286. Singh A, Joshi S, Zulcic M, Alcaraz M, GARLICH J, Morales G, et al. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma. PLoS ONE. 2016;11:e0150836 pubmed publisher
  287. Nakayama R, Zhang Y, Czaplinski J, Anatone A, Sicinska E, Fletcher J, et al. Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma. Oncotarget. 2016;7:16581-92 pubmed publisher
  288. Colangelo T, Polcaro G, Ziccardi P, Muccillo L, Galgani M, Pucci B, et al. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death Dis. 2016;7:e2108 pubmed publisher
  289. Gao S, Chen X, Jin H, Ren S, Liu Z, Fang X, et al. Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane. Oncol Lett. 2016;11:1567-1573 pubmed
  290. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed publisher
  291. Zhang W, Shi H, Zhang M, Liu B, Mao S, Li L, et al. Poly C binding protein 1 represses autophagy through downregulation of LC3B to promote tumor cell apoptosis in starvation. Int J Biochem Cell Biol. 2016;73:127-136 pubmed publisher
  292. Hung M, Chen Y, Chu P, Shih C, Yu H, Tai W, et al. Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential. Oncogene. 2016;35:4891-902 pubmed publisher
  293. Hong M, Nam K, Kim K, Kim S, Kim I. The small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives regulate global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha. Cell Stress Chaperones. 2016;21:485-97 pubmed publisher
  294. Pesakhov S, Nachliely M, Barvish Z, Aqaqe N, Schwartzman B, Voronov E, et al. Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid. Oncotarget. 2016;7:31847-61 pubmed publisher
  295. Kim N, Kim M, Sung P, Bae Y, Shin E, Yoo J. Interferon-inducible protein SCOTIN interferes with HCV replication through the autolysosomal degradation of NS5A. Nat Commun. 2016;7:10631 pubmed publisher
  296. Tang Y, Hong Y, Bai H, Wu Q, Chen C, Lang J, et al. Plant Homeo Domain Finger Protein 8 Regulates Mesodermal and Cardiac Differentiation of Embryonic Stem Cells Through Mediating the Histone Demethylation of pmaip1. Stem Cells. 2016;34:1527-40 pubmed publisher
  297. Ding M, Bruick R, Yu Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat Cell Biol. 2016;18:319-27 pubmed publisher
  298. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed publisher
  299. Lopez J, Bessou M, Riley J, Giampazolias E, Todt F, Rochegüe T, et al. Mito-priming as a method to engineer Bcl-2 addiction. Nat Commun. 2016;7:10538 pubmed publisher
  300. Ware M, Colbert K, Keshishian V, Ho J, Corr S, Curley S, et al. Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique. Tissue Eng Part C Methods. 2016;22:312-21 pubmed publisher
  301. Podmirseg S, Jäkel H, Ranches G, Kullmann M, Sohm B, Villunger A, et al. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 2016;35:4580-90 pubmed publisher
  302. Soriano A, París Coderch L, Jubierre L, Martínez A, Zhou X, Piskareva O, et al. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget. 2016;7:9271-87 pubmed publisher
  303. Yan Y, Tan K, Li C, Tran T, Chao S, Sugrue R, et al. Human nasal epithelial cells derived from multiple subjects exhibit differential responses to H3N2 influenza virus infection in vitro. J Allergy Clin Immunol. 2016;138:276-281.e15 pubmed publisher
  304. Koyani C, Kitz K, Rossmann C, Bernhart E, Huber E, Trummer C, et al. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death. Biochem Pharmacol. 2016;104:29-41 pubmed publisher
  305. Rasmussen R, Gajjar M, Jensen K, Hamerlik P. Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma. Mol Oncol. 2016;10:751-63 pubmed publisher
  306. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  307. Korwitz A, Merkwirth C, Richter Dennerlein R, Tröder S, Sprenger H, Quirós P, et al. Loss of OMA1 delays neurodegeneration by preventing stress-induced OPA1 processing in mitochondria. J Cell Biol. 2016;212:157-66 pubmed publisher
  308. Du Y, Yamaguchi H, Wei Y, Hsu J, Wang H, Hsu Y, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. 2016;22:194-201 pubmed publisher
  309. Pivonello C, Negri M, De Martino M, Napolitano M, De Angelis C, Provvisiero D, et al. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 2016;7:9718-31 pubmed publisher
  310. Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, et al. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation. Mol Cancer. 2016;15:3 pubmed publisher
  311. Liberante F, Pouryahya T, McMullin M, Zhang S, Mills K. Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Oncotarget. 2016;7:6609-19 pubmed publisher
  312. Wilhelm K, Happel K, Eelen G, Schoors S, Oellerich M, Lim R, et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature. 2016;529:216-20 pubmed publisher
  313. Han M, Lee D, Woo S, Seo B, Min K, Kim S, et al. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells. Sci Rep. 2016;6:18642 pubmed publisher
  314. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed publisher
  315. Mir R, Bele A, Mirza S, Srivastava S, Olou A, Ammons S, et al. A Novel Interaction of Ecdysoneless (ECD) Protein with R2TP Complex Component RUVBL1 Is Required for the Functional Role of ECD in Cell Cycle Progression. Mol Cell Biol. 2015;36:886-99 pubmed publisher
  316. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed publisher
  317. Borriello A, Naviglio S, Bencivenga D, Caldarelli I, Tramontano A, Speranza M, et al. Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation. Oxid Med Cell Longev. 2016;2016:2481865 pubmed publisher
  318. Yuniati L, van der Meer L, Tijchon E, van Ingen Schenau D, van Emst L, Levers M, et al. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress. Oncotarget. 2016;7:3128-43 pubmed publisher
  319. Obermeier K, Sachsenweger J, Friedl T, Pospiech H, Winqvist R, Wiesmüller L. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients. Oncogene. 2016;35:3796-806 pubmed publisher
  320. Cataldo A, Cheung D, Balsari A, Tagliabue E, Coppola V, Iorio M, et al. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget. 2016;7:786-97 pubmed publisher
  321. Song H, Tao L, Chen C, Pan L, Hao J, Ni Y, et al. USP17-mediated deubiquitination and stabilization of HDAC2 in cigarette smoke extract-induced inflammation. Int J Clin Exp Pathol. 2015;8:10707-15 pubmed
  322. Ni Y, Tao L, Chen C, Song H, Li Z, Gao Y, et al. The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. Int J Mol Sci. 2015;16:27956-66 pubmed publisher
  323. Chen J, Chen Y, Yen C, Chen W, Huang W. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget. 2016;7:473-89 pubmed publisher
  324. Cristini A, Park J, Capranico G, Legube G, Favre G, Sordet O. DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions. Nucleic Acids Res. 2016;44:1161-78 pubmed publisher
  325. El Khattouti A, Selimovic D, Hannig M, Taylor E, Abd Elmageed Z, Hassan S, et al. Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition. J Cell Mol Med. 2016;20:266-86 pubmed publisher
  326. Alsafadi S, Tourpin S, Bessoltane N, Salomé Desnoulez S, Vassal G, André F, et al. Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget. 2016;7:12331-43 pubmed publisher
  327. Maxfield K, Taus P, Corcoran K, Wooten J, Macion J, Zhou Y, et al. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer. Nat Commun. 2015;6:8840 pubmed publisher
  328. Holmberg Olausson K, Elsir T, Moazemi Goudarzi K, Nistér M, Lindström M. NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. Sci Rep. 2015;5:16495 pubmed publisher
  329. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed publisher
  330. Hwang K, Choi Y. Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1. J Virol. 2016;90:506-20 pubmed publisher
  331. Hassan M, El Khattouti A, Ejaeidi A, Ma T, Day W, Espinoza I, et al. Elevated Expression of Hepatoma Up-Regulated Protein Inhibits γ-Irradiation-Induced Apoptosis of Prostate Cancer Cells. J Cell Biochem. 2016;117:1308-18 pubmed publisher
  332. Xu S, Huang J, Chen M, Zeng M, Zou F, Chen D, et al. Amplification of ACK1 promotes gastric tumorigenesis via ECD-dependent p53 ubiquitination degradation. Oncotarget. 2017;8:12705-12716 pubmed publisher
  333. Campo Verde Arboccó F, Sasso C, Actis E, Carón R, Hapon M, Jahn G. Hypothyroidism advances mammary involution in lactating rats through inhibition of PRL signaling and induction of LIF/STAT3 mRNAs. Mol Cell Endocrinol. 2016;419:18-28 pubmed publisher
  334. Sabirzhanov B, Stoica B, Zhao Z, Loane D, Wu J, Dorsey S, et al. miR-711 upregulation induces neuronal cell death after traumatic brain injury. Cell Death Differ. 2016;23:654-68 pubmed publisher
  335. Young L, Marzio A, Pérez Durán P, Reid D, Meredith D, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13:451-459 pubmed publisher
  336. Hwang J, Sung W, Tu H, Hsieh K, Yeh C, Chen C, et al. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma. PLoS ONE. 2015;10:e0139435 pubmed publisher
  337. Hu D, Gur M, Zhou Z, Gamper A, Hung M, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419 pubmed publisher
  338. Pelish H, Liau B, Nitulescu I, Tangpeerachaikul A, Poss Z, Da Silva D, et al. Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature. 2015;526:273-276 pubmed publisher
  339. Hilton B, Li Z, Musich P, Wang H, Cartwright B, SERRANO M, et al. ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1. Mol Cell. 2015;60:35-46 pubmed publisher
  340. Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, et al. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Oncotarget. 2015;6:31378-98 pubmed publisher
  341. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  342. Charni M, Molchadsky A, Goldstein I, Solomon H, Tal P, Goldfinger N, et al. Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation. Cell Death Differ. 2016;23:509-20 pubmed publisher
  343. Machado Neto J, de Melo Campos P, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand Metze I, et al. Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. Oncotarget. 2015;6:29573-84 pubmed publisher
  344. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  345. Weaver A, Cooper T, Rodriguez M, Trummell H, Bonner J, Rosenthal E, et al. DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma. Oncotarget. 2015;6:26995-7007 pubmed publisher
  346. Tiffen J, Gunatilake D, Gallagher S, Gowrishankar K, Heinemann A, Cullinane C, et al. Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes. Oncotarget. 2015;6:27023-36 pubmed publisher
  347. Li X, Liang Q, Liu W, Zhang N, Xu L, Zhang X, et al. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway. Oncogene. 2016;35:2453-64 pubmed publisher
  348. Fan L, Peng G, Sahgal N, Fazli L, Gleave M, Zhang Y, et al. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Oncogene. 2016;35:2441-52 pubmed publisher
  349. Sakabe I, Hu R, Jin L, Clarke R, Kasid U. TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling. Breast Cancer Res Treat. 2015;153:285-97 pubmed publisher
  350. Hermanova I, Arruabarrena Aristorena A, Valis K, Nůsková H, Alberich Jorda M, Fiser K, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 2016;30:209-18 pubmed publisher
  351. Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 2015;5:12579 pubmed publisher
  352. Dahlhoff M, Schäfer M, Muzumdar S, Rose C, Schneider M. ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis. Mol Oncol. 2015;9:1825-33 pubmed publisher
  353. Zhang L, Dai F, Sheng P, Chen Z, Xu Q, Guo Y. Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro. Acta Pharmacol Sin. 2015;36:1256-65 pubmed publisher
  354. Sarojini S, Pecora A, Milinovikj N, Barbiere J, Gupta S, Hussain Z, et al. A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes. Melanoma Res. 2015;25:376-89 pubmed publisher
  355. Berens C, Bisle S, Klingenbeck L, Lührmann A. Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling. J Vis Exp. 2015;:e52903 pubmed publisher
  356. Patergnani S, Giorgi C, Maniero S, Missiroli S, Maniscalco P, Bononi I, et al. The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition. Oncotarget. 2015;6:23427-44 pubmed
  357. Sun Q, Jin C, Zhu L, Liang M, Li C, Cardona C, et al. Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus. Sci Rep. 2015;5:11816 pubmed publisher
  358. Ciamporcero E, Shen H, Ramakrishnan S, Yu Ku S, Chintala S, Shen L, et al. YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene. 2016;35:1541-53 pubmed publisher
  359. Liu K, Chuang S, Long C, Lee Y, Wang C, Lu M, et al. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. Am J Physiol Renal Physiol. 2015;309:F318-31 pubmed publisher
  360. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  361. Bock F, Tanzer M, Haschka M, Krumschnabel G, Sohm B, Goetsch K, et al. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death. Sci Rep. 2015;5:11268 pubmed publisher
  362. Amente S, Milazzo G, Sorrentino M, Ambrosio S, Di Palo G, Lania L, et al. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma. Oncotarget. 2015;6:14572-83 pubmed
  363. Krossa S, Schmitt A, Hattermann K, Fritsch J, Scheidig A, Mehdorn H, et al. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1. Oncotarget. 2015;6:21029-45 pubmed
  364. Izhar L, Adamson B, Ciccia A, Lewis J, Pontano Vaites L, Leng Y, et al. A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors. Cell Rep. 2015;11:1486-500 pubmed publisher
  365. Yang K, Kohler R, Landon M, Giedt R, Weissleder R. Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 2015;5:10129 pubmed publisher
  366. Kumar S, Ingle H, Mishra S, Mahla R, Kumar A, Kawai T, et al. IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity. Cell Death Dis. 2015;6:e1758 pubmed publisher
  367. Huang C, Chao C, Lee Y, Lu M, Cheng J, Yang Y, et al. Paraquat Induces Cell Death Through Impairing Mitochondrial Membrane Permeability. Mol Neurobiol. 2016;53:2169-88 pubmed publisher
  368. Suzuki M, Takeda T, Nakagawa H, Iwata S, Watanabe T, Siddiquey M, et al. The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas. Front Microbiol. 2015;6:280 pubmed publisher
  369. Luo T, Fu J, Xu A, Su B, Ren Y, Li N, et al. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression. Autophagy. 2016;12:1355-71 pubmed publisher
  370. Zhang P, Yang X, Ma X, Ingram D, Lazar A, Torres K, et al. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway. Mol Cancer. 2015;14:55 pubmed publisher
  371. Ferreira R, Law M, Jahn S, Davis B, Heldermon C, Reinhard M, et al. Novel agents that downregulate EGFR, HER2, and HER3 in parallel. Oncotarget. 2015;6:10445-59 pubmed
  372. Zhang D, Zhu L, Li C, Mu J, Fu Y, Zhu Q, et al. Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction. Basic Res Cardiol. 2015;110:28 pubmed publisher
  373. Neira Peña T, Rojas Mancilla E, Munoz Vio V, Perez R, Gutierrez Hernandez M, Bustamante D, et al. Perinatal asphyxia leads to PARP-1 overactivity, p65 translocation, IL-1β and TNF-α overexpression, and apoptotic-like cell death in mesencephalon of neonatal rats: prevention by systemic neonatal nicotinamide administration. Neurotox Res. 2015;27:453-65 pubmed publisher
  374. Zub K, Sousa M, Sarno A, Sharma A, Demirovic A, Rao S, et al. Modulation of cell metabolic pathways and oxidative stress signaling contribute to acquired melphalan resistance in multiple myeloma cells. PLoS ONE. 2015;10:e0119857 pubmed publisher
  375. Hodgson A, Wier E, Fu K, Sun X, Yu H, Zheng W, et al. Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction. PLoS Pathog. 2015;11:e1004705 pubmed publisher
  376. Wu Z, Wang C, Bai M, Li X, Mei Q, Li X, et al. An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks. Nucleic Acids Res. 2015;43:3167-79 pubmed publisher
  377. Grabner B, Schramek D, Mueller K, Moll H, Svinka J, Hoffmann T, et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat Commun. 2015;6:6285 pubmed publisher
  378. Xie Q, Wu Q, Horbinski C, Flavahan W, Yang K, Zhou W, et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci. 2015;18:501-10 pubmed publisher
  379. Suganya R, Chakraborty A, Miriyala S, Hazra T, Izumi T. Suppression of oxidative phosphorylation in mouse embryonic fibroblast cells deficient in apurinic/apyrimidinic endonuclease. DNA Repair (Amst). 2015;27:40-8 pubmed publisher
  380. Lu K, Fang X, Feng L, Jiang Y, Zhou X, Liu X, et al. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6. Cancer Lett. 2015;359:250-8 pubmed publisher
  381. Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs R, et al. A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discov. 2015;5:396-409 pubmed publisher
  382. Tao Y, Xu L, Lu J, Hu S, Fang F, Cao L, et al. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia. J Exp Clin Cancer Res. 2015;34:4 pubmed publisher
  383. Jackson T, Du L, Janesko Feldman K, Vagni V, Dezfulian C, Poloyac S, et al. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2015;35:655-66 pubmed publisher
  384. Majuelos Melguizo J, Rodríguez M, López Jiménez L, Rodríguez Vargas J, Martí Martín Consuegra J, Serrano Sáenz S, et al. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget. 2015;6:4790-803 pubmed
  385. Xia J, Chen S, Lv Y, Lu L, Hu W, Zhou Y. ZGDHu-1 induces Gâ‚‚/M phase arrest and apoptosis in Kasumi-1 cells. Mol Med Rep. 2015;11:3398-404 pubmed publisher
  386. Newman E, Lu F, Bashllari D, Wang L, Opipari A, Castle V. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma. Mol Cancer Res. 2015;13:470-82 pubmed publisher
  387. Mudie S, Bandarra D, Batie M, Biddlestone J, Moniz S, Ortmann B, et al. PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia. Cell Cycle. 2014;13:3878-91 pubmed publisher
  388. Mir S, George N, Zahoor L, Harms R, Guinn Z, SARVETNICK N. Inhibition of autophagic turnover in β-cells by fatty acids and glucose leads to apoptotic cell death. J Biol Chem. 2015;290:6071-85 pubmed publisher
  389. Zanotto Filho A, Braganhol E, Klafke K, Figueiró F, Terra S, Paludo F, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett. 2015;358:220-31 pubmed publisher
  390. Papanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, et al. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes. Cell Oncol (Dordr). 2015;38:155-64 pubmed publisher
  391. Zhang X, Cheng S, Bian K, Wang L, Zhang X, Yan B, et al. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin. Oncotarget. 2015;6:2277-89 pubmed
  392. Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson S, et al. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. 2015;34:4879-89 pubmed publisher
  393. Wang S, Park S, Kodali V, Han J, Yip T, Chen Z, et al. Identification of protein disulfide isomerase 1 as a key isomerase for disulfide bond formation in apolipoprotein B100. Mol Biol Cell. 2015;26:594-604 pubmed publisher
  394. Girotti M, Lopes F, Preece N, Niculescu Duvaz D, Zambon A, Davies L, et al. Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell. 2015;27:85-96 pubmed publisher
  395. Ma H, Yue X, Gao L, Liang X, Yan W, Zhang Z, et al. ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. Oncotarget. 2015;6:1049-63 pubmed
  396. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  397. Riggi N, Knoechel B, Gillespie S, Rheinbay E, Boulay G, Suvà M, et al. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell. 2014;26:668-681 pubmed publisher
  398. Ohoka N, Nagai K, Hattori T, Okuhira K, Shibata N, Cho N, et al. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway. Cell Death Dis. 2014;5:e1513 pubmed publisher
  399. Gao S, Andreeva K, Cooper N. Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway. Mol Vis. 2014;20:1374-87 pubmed
  400. Holland W, Chinn D, Lara P, Gandara D, Mack P. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol. 2015;141:615-26 pubmed publisher
  401. Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, et al. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. PLoS ONE. 2014;9:e109076 pubmed publisher
  402. Steffensen M, Fenger C, Christensen J, Jørgensen C, Bassi M, Christensen J, et al. Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways. J Virol. 2014;88:14090-104 pubmed publisher
  403. Geserick P, Wang J, Feoktistova M, Leverkus M. The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin. Cell Death Dis. 2014;5:e1412 pubmed publisher
  404. Krukenberg K, Jiang R, Steen J, Mitchison T. Basal activity of a PARP1-NuA4 complex varies dramatically across cancer cell lines. Cell Rep. 2014;8:1808-1818 pubmed publisher
  405. Tao L, Chen C, Song H, Piccioni M, Shi G, Li B. Deubiquitination and stabilization of IL-33 by USP21. Int J Clin Exp Pathol. 2014;7:4930-7 pubmed
  406. Casella C, Miller D, Lynch K, Brodsky A. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Gynecol Oncol. 2014;135:333-41 pubmed publisher
  407. Senturk S, Yao Z, Camiolo M, Stiles B, Rathod T, Walsh A, et al. p53? is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state. Proc Natl Acad Sci U S A. 2014;111:E3287-96 pubmed publisher
  408. Resch U, Cuapio A, Sturtzel C, Hofer E, de Martin R, Holper Schichl Y. Polyubiquitinated tristetraprolin protects from TNF-induced, caspase-mediated apoptosis. J Biol Chem. 2014;289:25088-100 pubmed publisher
  409. Roper S, Chrysanthou S, Senner C, Sienerth A, Gnan S, Murray A, et al. ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells. Nucleic Acids Res. 2014;42:8914-27 pubmed publisher
  410. Cazanave S, Wang X, Zhou H, Rahmani M, Grant S, Durrant D, et al. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ. 2014;21:1303-12 pubmed publisher
  411. Hegde V, Vogel R, Feany M. Glia are critical for the neuropathology of complex I deficiency in Drosophila. Hum Mol Genet. 2014;23:4686-92 pubmed publisher
  412. Chou C, Huang N, Jhuang S, Pan H, Peng N, Cheng J, et al. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PLoS ONE. 2014;9:e93934 pubmed publisher
  413. Matsumoto T, Tabata K, Suzuki T. The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells. Biol Pharm Bull. 2014;37:633-41 pubmed
  414. Bhattacharyya S, Ghosh S, Sil P. Amelioration of aspirin induced oxidative impairment and apoptotic cell death by a novel antioxidant protein molecule isolated from the herb Phyllanthus niruri. PLoS ONE. 2014;9:e89026 pubmed publisher
  415. Brubaker S, Gauthier A, Mills E, Ingolia N, Kagan J. A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity. Cell. 2014;156:800-11 pubmed publisher
  416. Rubio N, Verrax J, Dewaele M, Verfaillie T, Johansen T, Piette J, et al. p38(MAPK)-regulated induction of p62 and NBR1 after photodynamic therapy promotes autophagic clearance of ubiquitin aggregates and reduces reactive oxygen species levels by supporting Nrf2-antioxidant signaling. Free Radic Biol Med. 2014;67:292-303 pubmed publisher
  417. Gastaldello S, Chen X, Callegari S, Masucci M. Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells. PLoS Pathog. 2013;9:e1003664 pubmed publisher
  418. Tesoriere L, Attanzio A, Allegra M, Gentile C, Livrea M. Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-?B-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1?-exposed Caco-2 cells. Br J Nutr. 2014;111:415-23 pubmed publisher
  419. Lonskaya I, Hebron M, Algarzae N, Desforges N, Moussa C. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease. Neuroscience. 2013;232:90-105 pubmed publisher
  420. Wu X, Ellmann S, Rubin E, Gil M, Jin K, Han L, et al. ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity. PLoS ONE. 2012;7:e40644 pubmed publisher
  421. Benatti P, Dolfini D, Vigano A, Ravo M, Weisz A, Imbriano C. Specific inhibition of NF-Y subunits triggers different cell proliferation defects. Nucleic Acids Res. 2011;39:5356-68 pubmed publisher
  422. Sémiramoth N, Gleizes A, Turbica I, Sandré C, Marin Esteban V, Gorges R, et al. Afa/Dr-expressing, diffusely adhering Escherichia coli strain C1845 triggers F1845 fimbria-dependent phosphatidylserine externalization on neutrophil-like differentiated PLB-985 cells through an apoptosis-independent mechanism. Infect Immun. 2010;78:2974-83 pubmed publisher
  423. Koschny R, Holland H, Sykora J, Erdal H, Krupp W, Bauer M, et al. Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. J Neurooncol. 2010;97:171-85 pubmed publisher
  424. Rossi M, Carbone M, Mostocotto C, Mancone C, Tripodi M, Maione R, et al. Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J Biol Chem. 2009;284:31616-24 pubmed publisher
  425. Yung T, Narita T, Komori T, Yamaguchi Y, Handa H. Cellular dynamics of the negative transcription elongation factor NELF. Exp Cell Res. 2009;315:1693-705 pubmed publisher
  426. Koschny R, Ganten T, Sykora J, Haas T, Sprick M, Kolb A, et al. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology. 2007;45:649-58 pubmed
  427. Martin Latil S, Mousson L, Autret A, Colbere Garapin F, Blondel B. Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway. J Virol. 2007;81:4457-64 pubmed
  428. Zhu C, Wang X, Huang Z, Qiu L, Xu F, Vahsen N, et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 2007;14:775-84 pubmed
  429. Duensing A, Medeiros F, McConarty B, Joseph N, Panigrahy D, Singer S, et al. Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene. 2004;23:3999-4006 pubmed